prednisolone has been researched along with Angiitis in 256 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Standard therapy for antineutrophil cytoplasmic antibody-associated systemic vasculitis (AASV) with cyclophosphamide (CYC) and prednisolone is limited by toxicity." | 9.11 | Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. ( Bacon, PA; De Groot, K; Feighery, C; Gregorini, G; Gross, WL; Jayne, DR; Luqmani, R; Rasmussen, N; Tervaert, JW, 2005) |
| "Although cyclophosphamide and prednisolone are effective in treating systemic vasculitis, the optimum treatment regimes and duration of treatment are unknown." | 9.08 | Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. ( Adu, D; Bacon, PA; Emery, P; Howie, AJ; Luqmani, RA; Michael, J; Pall, A; Richards, NT; Savage, CO, 1997) |
| "We report a chronic case of nodular vasculitis that responded to oral clofazimine 300 mg daily." | 7.78 | Clofazimine-induced enteropathy in treatment-resistant nodular vasculitis. ( Hill, P; Kelly, R; Kieu, V; Williams, R, 2012) |
| "Mizoribine (MZR) has shown to be effective against antineutrophil cytoplasmic antibody (ANCA)-related vasculitis; however, no reports have described the successful treatment of steroid-resistant ANCA-related vasculitis with MZR in patients with renal insufficiency requiring hemodialysis." | 7.75 | A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient. ( Abe, H; Fujimatsu, S; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Muta, T; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M, 2009) |
| "Reports of histologically proven low-dose methotrexate (MTX)-induced vasculitis are uncommon and mostly found for patients with rheumatoid arthritis." | 7.70 | Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis. ( Bodur, H; Borman, P; Güleç, AT; Mocan, G; Seçkin, U; Uçan, H, 2000) |
| "Immunosuppressive doses of prednisolone were used to treat severe vasculitis in two patients with early primary biliary cirrhosis." | 7.68 | Vasculitis in primary biliary cirrhosis--response to prednisolone. ( Bassendine, MF; Crook, P; James, OF; Mutimer, DJ, 1990) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Testicular vasculitis is a rare condition and little is known about its morphological features." | 5.46 | Testicular lymphocytic vasculitis treated with prednisolone and azathioprine. ( Imai, Y; Kanzawa, Y; Mizuno, Y; Nishioka, H, 2017) |
| "Mizoribine is an immunosuppressive agent that was developed in Japan and has been found to inhibit the proliferation of lymphocytes, especially B cells." | 5.34 | Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers. ( Hamaguchi, M; Ishino, H; Kawahito, Y; Kohno, M; Tsubouchi, Y; Wada, M; Yamamoto, A; Yoshikawa, T, 2007) |
| " The patient received ampicillin for the infection and prednisolone for vasculitis." | 5.12 | Hard bilateral syphilitic testes with vasculitis: a case report and literature review. ( Amano, S; Fukagai, T; Inoue, T; Kato, R; Kurokawa, M; Maeda, Y; Mizunuma, M; Morita, J; Nakagami, Y; Nakasato, T; Nepal, SP; Noguchi, T; Ogawa, Y; Oshinomi, K; Shichijo, T; Tsunokawa, Y; Unoki, T; Yasuda, S, 2021) |
| "Standard therapy for antineutrophil cytoplasmic antibody-associated systemic vasculitis (AASV) with cyclophosphamide (CYC) and prednisolone is limited by toxicity." | 5.11 | Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. ( Bacon, PA; De Groot, K; Feighery, C; Gregorini, G; Gross, WL; Jayne, DR; Luqmani, R; Rasmussen, N; Tervaert, JW, 2005) |
| " We investigated whether exposure to cyclophosphamide in patients with generalized vasculitis could be reduced by substitution of azathioprine at remission." | 5.10 | A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. ( Andrassy, K; Bacon, P; Dadoniené, J; de Groot, K; Ekstrand, A; Gaskin, G; Gregorini, G; Gross, W; Hagen, EC; Jayne, D; Mirapeix, E; Pettersson, E; Pusey, C; Rasmussen, N; Siegert, C; Sinico, A; Tervaert, JW; Tesar, V; Westman, K, 2003) |
| "Although cyclophosphamide and prednisolone are effective in treating systemic vasculitis, the optimum treatment regimes and duration of treatment are unknown." | 5.08 | Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. ( Adu, D; Bacon, PA; Emery, P; Howie, AJ; Luqmani, RA; Michael, J; Pall, A; Richards, NT; Savage, CO, 1997) |
| "The introduction of cyclophosphamide- and prednisolone-based treatment regimens has significantly improved outcome in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis." | 4.85 | Adverse effects of therapy for ANCA-associated vasculitis. ( Harper, L; Turnbull, J, 2009) |
| "The multiple neuropathy (cryoglobulinaemia neuropathy), associated with hepatitis C, was treated with corticosteroids (starting with 60 mg/d prednisolone) and the neurological abnormalities regressed well." | 4.79 | [Hepatitis C-associated vasculitic mononeuritis multiplex]. ( Blum, HE; Druschky, A; Engelhardt, A; Heckmann, JG; Neundörfer, B, 1997) |
| " The patient showed persistent proteinuria and a systemic steroid (prednisolone 50 mg [1 mg/kg]) was started." | 4.02 | IgA vasculitis mimicking drug-induced skin reaction and infectious colitis in an elderly patient: A case report. ( Seo, SY; Yim, SK, 2021) |
| " Hypocomplementemic urticarial vasculitis improved after CZP was discontinued and the dose of oral prednisolone was increased." | 3.96 | Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report. ( Horai, Y; Ishikawa, H; Iwanaga, N; Izumi, Y; Kawakami, A; Matsuoka, Y; Miura, S, 2020) |
| " He was diagnosed with type I cryoglobulinemia and treated with rituximab, plasmapheresis, methylprednisolone, and ibrutinib was restarted." | 3.91 | Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL). ( Field, J; George, G; Singavi, A; Voshtina, E; Wright, N, 2019) |
| " A total of 91 patients with systemic autoimmune diseases who received initial glucocorticoid therapy with prednisolone (30-60 mg daily) were prospectively enrolled." | 3.88 | Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases. ( Kaneko, K; Kawai, S; Kawazoe, M; Kusunoki, N; Nanki, T; Shikano, K, 2018) |
| " She had a 7-year history of rheumatoid arthritis (RA), which had been treated with methotrexate (MTX) and prednisolone." | 3.85 | Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system. ( Anei, R; Asanome, A; Hasebe, N; Kamada, K; Kano, K; Katayama, T; Miyokawa, N; Nishihara, H; Saito, M; Saito, T; Sawada, J; Takahashi, K; Takeguchi, S, 2017) |
| "A 46-year-old man who was diagnosed with IgA vasculitis (IgAV) at the age of 38 was treated with prednisolone and mizoribine." | 3.85 | A novel case of renal pathergy reaction in a Behçet's disease patient complicated by IgA vasculitis. ( Higashihara, T; Ishigaki, K; Kusano, T; Okada, A; Shimizu, A; Takano, H, 2017) |
| "We report a chronic case of nodular vasculitis that responded to oral clofazimine 300 mg daily." | 3.78 | Clofazimine-induced enteropathy in treatment-resistant nodular vasculitis. ( Hill, P; Kelly, R; Kieu, V; Williams, R, 2012) |
| "Mizoribine (MZR) has shown to be effective against antineutrophil cytoplasmic antibody (ANCA)-related vasculitis; however, no reports have described the successful treatment of steroid-resistant ANCA-related vasculitis with MZR in patients with renal insufficiency requiring hemodialysis." | 3.75 | A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient. ( Abe, H; Fujimatsu, S; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Muta, T; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M, 2009) |
| "The patient received oral prednisolone 15 mg daily for polymyalgia rheumatica along with alendronate 70 mg weekly." | 3.73 | A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma. ( Chakravarty, K; Hakim, A; Hughes, R; Keat, A; Kuttikat, A, 2006) |
| "A 19 year old man with severe acne conglobata and ulcerated pyoderma gangraenosum-like skin lesions on the face was first treated with isotretinoin (Roaccutan((R))), then immunosuppressively with prednisolone, diaminodiphenylsulfone (Dapson-Fatol((R))) and mycophenolate mofetil (Cellcept((R)))." | 3.71 | [ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata]. ( Manz, B; Mittag, M; Nenoff, P; Rytter, M; Seidel, W, 2002) |
| "While being treated with corticosteroids and methotrexate for rheumatoid arthritis, a 63-year-old man developed livid nodules on his lower arms, hands and feet, as well as fever, necrotizing skin ulcers and rupture of a finger extensor tendon." | 3.71 | [Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis]. ( Böcher, W; Galle, PR; Märker-Hermann, E, 2002) |
| " The course of the disease and the shape of the lesions strongly suggested involvement of rheumatoid vasculitis; oral administration of prednisolone was effective." | 3.70 | Rheumatoid arthritis accompanied by colonic lesions. ( Matake, H; Matsui, T; Matsumura, M; Nagahama, T; Sakurai, T; Schlemper, R; Tsuda, S; Yao, T, 2000) |
| "Reports of histologically proven low-dose methotrexate (MTX)-induced vasculitis are uncommon and mostly found for patients with rheumatoid arthritis." | 3.70 | Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis. ( Bodur, H; Borman, P; Güleç, AT; Mocan, G; Seçkin, U; Uçan, H, 2000) |
| " Immunosuppressive treatment with initially 60mg/d prednisolone improved the skin condition but activated the chronic hepatitis, GPT rising up to 240 U/l." | 3.69 | [Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy]. ( Glück, T; Weber, P; Wiedmann, KH, 1994) |
| " We describe a patient with Wegener's granulomatosis in whom there was evidence of significant inner ear damage caused by vasculitis, which was completely reversed by cyclophosphamide and prednisolone." | 3.68 | Inner ear deafness in Wegener's granulomatosis. ( Adu, D; Emery, P; Jubb, R; Luqmani, R; Reid, A, 1991) |
| "Immunosuppressive doses of prednisolone were used to treat severe vasculitis in two patients with early primary biliary cirrhosis." | 3.68 | Vasculitis in primary biliary cirrhosis--response to prednisolone. ( Bassendine, MF; Crook, P; James, OF; Mutimer, DJ, 1990) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Propylthiouracil was substituted for MMI and HTLV-1-associated uveitis (HAU) has not recurred." | 2.41 | Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease. ( Maruyama, T; Nakashima, K; Sano, A; Sarui, H; Takeda, N; Yasuda, K, 2002) |
| "The second patient suffered from sylvian subarachnoid hemorrhage along with multiple intracerebral hemorrhages, with angiography that was diagnostic for angiitis." | 2.39 | Primary angiitis of the central nervous system: report of two cases and review of the literature. ( Ozawa, T; Sasaki, O; Sorimachi, T; Tanaka, R, 1995) |
| "It is hypothesized that Borrelia burgdorferi infection may cause a systemic vasculitis following its own course and requiring its own treatment." | 2.38 | [Multiple mononeuritis and cerebral meningo-arteritis. Wegener disease or Lyme disease?]. ( Archambaud, M; Arné-Bès, MC; Bès, A; Delisle, MB; Delpla, PA; Géraud, G, 1993) |
| "Vasculitis is rare in childhood, apart from Henoch-Schönlein purpura, and paediatric nephrologists see few cases of Wegener's granuloma or microscopic polyarteritis." | 2.37 | Renal disease and vasculitis. ( Cameron, JS, 1988) |
| "Cutaneous arteritis (CA) is necrotizing vasculitis invading the small- to medium-sized arteries of the skin." | 1.62 | Development of a prediction model of treatment response in patients with cutaneous arteritis: Insights from a cohort of 33 patients. ( Ebata, S; Fukasawa, T; Fukayama, M; Kotani, H; Kuzumi, A; Matsuda, KM; Sato, S; Yoshizaki, A; Yoshizaki-Ogawa, A, 2021) |
| "Diffuse alveolar hemorrhage is an uncommon and often fatal condition in children that is characterized by distinct histopathological etiologies." | 1.51 | Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis. ( Asseri, AA; Daines, CL; Zeng, Y, 2019) |
| "Testicular vasculitis is a rare condition and little is known about its morphological features." | 1.46 | Testicular lymphocytic vasculitis treated with prednisolone and azathioprine. ( Imai, Y; Kanzawa, Y; Mizuno, Y; Nishioka, H, 2017) |
| "A neurological examination showed mononeuritis multiplex with laboratory evidence of hypocomplementemia, cryoglobulinemia and leukocytoclastic vasculitis in the biopsy of a skin specimen." | 1.43 | IgG4-Related Sialoadenitis with a Skin Lesion and Multiple Mononeuropathies Suggesting Coexistent Cryoglobulinemic Vasculitis. ( Kamiya, M; Kohsaka, H; Miyasaka, N; Shane, PY; Soejima, M; Tohda, S, 2016) |
| "A 75-year-old man with ulcerative colitis (UC) and diet controlled diabetes mellitus presented with a 3-week history of slightly itchy, red plaques on both lower limbs ascending gradually to cover the trunk and arms." | 1.40 | Florid urticarial vasculitis heralding a flare up of ulcerative colitis. ( Boules, E; Lyon, C, 2014) |
| "Intestinal vasculitis is a serious and often underrecognized complication of systemic lupus erythematosus (SLE) usually managed with high-dose corticosteroids." | 1.37 | Colitis associated with active systemic lupus erythematosus successfully treated with rituximab. ( Chiu, YH; George, E; Mane, S; Tayal, V, 2011) |
| "We report a rare case of lobular panniculitis with small vessel vasculitis, presenting with fever, cutaneous lesions, and systemic manifestations involving the visceral fat and associated with ulcerative colitis." | 1.37 | Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. ( Almerigogna, F; Beccastrini, E; Emmi, G; Emmi, L; Nesi, G; Squatrito, D, 2011) |
| " He was effectively managed with methylprednisolone pulse therapy (500 mg/day x 3 days) followed by progressive dosage tapering." | 1.35 | [Case of microscopic polyangiitis presenting initially as prostatic vasculitis]. ( Akizawa, T; Ashikaga, E; Iyoda, M; Nagai, H; Shibata, T; Suzuki, H, 2009) |
| "Laboratory tests indicated renal failure and proteinuria, as well as elevation of anti-neutrophilic cytoplasmic antibodies against proteinase 3 (PR3-ANCA)." | 1.35 | [Severe chronic headache with depression induced by pachymeningitis in Wegener's granulomatosis]. ( Fischer, V; Pelzer, C; von Bierbrauer, A, 2008) |
| "Antiphospholipid syndrome is an autoimmune disease characterized by recurrent thrombosis and the presence of antiphospholipid antibodies." | 1.35 | A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection. ( Arisoy, N; Baserer, T; Caliskan, S; Canpolat, N; Civilibal, M; Kasapcopur, O; Sever, L; Topal, N, 2008) |
| "He had depression and Alzheimer's disease as complications." | 1.34 | [An autopsy case of microscopic polyangiitis complicated with pulmonary aspergilloma and cytomegalovirus pneumonia]. ( Kimura, K; Konno, Y; Kuboshima, S; Miura, H; Okabayashi, J; Sakurada, T; Sasaki, H; Sato, T; Shima, Y; Shirai, S; Tsuruoka, K; Yasuda, T, 2007) |
| "Mizoribine is an immunosuppressive agent that was developed in Japan and has been found to inhibit the proliferation of lymphocytes, especially B cells." | 1.34 | Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers. ( Hamaguchi, M; Ishino, H; Kawahito, Y; Kohno, M; Tsubouchi, Y; Wada, M; Yamamoto, A; Yoshikawa, T, 2007) |
| "Vasculitis is often seen with SLE, but is usually limited to small vessels alone." | 1.34 | Extensive medium-vessel vasculitis with SLE: an unusual association. ( Agarwal, G; Ahlawat, R; Choudhary, N; Kaul, B; Kumar, N; Rizvi, Y, 2007) |
| "Hypertrophic pachymeningitis is a very unusual disease, the main characteristic of which is thickening of the dura mater." | 1.34 | [Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis]. ( Apa, NP; De Rosa, GE; Mazzocchi, O; Nadal, MA; Peralba, MC; Risso, JA; Viozzi, F, 2007) |
| "We describe a patient with ulcerative colitis (UC) who developed small vessel vasculitis." | 1.33 | Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis. ( Grigoriadou, M; Magira, E; Panani, AD; Raptis, SA; Roussos, C, 2006) |
| "Here we report two patients with severe juvenile dermatomyositis (JDM) complicated with extra musculocutaneous involvement." | 1.33 | Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement. ( Akalin, T; Aslan, MT; Gökben, S; Polat, M; Serdaroğlu, G; Tekgul, H; Tosun, A, 2006) |
| "Standard therapy of Wegener's granulomatosis is prednisolone in combination with cyclophosphamide." | 1.32 | [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis]. ( Stegeman, CA; Tervaert, JW, 2003) |
| "Her prednisolone was gradually reduced to 7 mg daily and cyclophosphamide was weaned, then substituted with azathioprine 100 mg daily." | 1.32 | Gallbladder vasculitis associated with cutaneous leucocytoclastic vasculitis. ( Manoharan, S; Muir, J, 2004) |
| "The prednisolone (PSL) dose was 0." | 1.31 | Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: report of five cases. ( Asano, S; Hasegawa, M; Kasugai, M; Kawamura, N; Koide, S; Kushimoto, H; Murakami, K; Murase, M; Shikano, M; Sugiyama, S; Toba, T; Tomita, M, 2002) |
| "To report a case of labial basal cell adenocarcinoma in a patient with uveitis on treatment with cyclosporin A." | 1.31 | Labial adenocarcinoma after treatment with cyclosporin a in a patient with panuveitis. ( Brown, AM; Murray, PI; Ramchandani, M; Rippin, JW, 2000) |
| "She subsequently developed cerebral vasculitis during treatment with oral cyclophosphamide and prednisolone." | 1.31 | Microscopic polyarteritis with renal and cerebral involvement. ( Alton, H; Deshpande, PV; Gilbert, R; Milford, DV, 2000) |
| "Cogan's syndrome is a rare, multisystem disease which occurs predominantly in children and young adults." | 1.31 | Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome. ( Bhathal, P; Jennens, I; McColl, G; Van Doornum, S; Walter, M; Wicks, IP, 2001) |
| "He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone." | 1.31 | Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy. ( Arakawa, M; Gejou, F; Imai, N; Miyamura, S; Nishi, S; Saeki, T; Shimada, H; Ueno, M, 2001) |
| "Generalized morphea is rarely associated with systemic overlap." | 1.31 | Necrotizing vasculitis in a patient with generalized morphea. ( Morita, A; Tsuji, T, 2001) |
| "They are normal in SLE, systemic sclerosis, and vasculitides as well as in non-rheumatic inflammatory controls, but are significantly increased by steroids." | 1.31 | Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. ( Damas, P; Franchimont, N; Houssiau, FA; Jaspar, JM; Kaiser, MJ; Malaise, MG; Martin y Porras, M; Ribbens, C, 2002) |
| "However, its association with juvenile dermatomyositis is extremely rare." | 1.31 | Juvenile dermatomyositis complicated with vasculitis and duodenal perforation. ( Chiang, BL; Hsu, WM; Ni, YH; Shun, CT; Wang, IJ, 2001) |
| "A case of systemic lupus erythematosus (SLE) associated with serositis presenting with disseminated intravascular coagulation (DIC) is reported." | 1.31 | Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation. ( Kageyama, Y; Miyairi, M; Yagi, T, 2002) |
| "Retinal neovascularization was detected during the follow-up." | 1.31 | Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease. ( Durak, I; Ergin, MH; Koçak, N; Saatci, OA, 2001) |
| "However, classic polyarteritis nodosa should always be considered as a possibility for those patients with mild renal insufficiency and a low titre of MPO-ANCA." | 1.31 | [Two cases of classical polyarteritis nodosa associated with a low titre of MPO-ANCA]. ( Bohgaki, T; Kohno, M; Mukai, M; Notoya, A, 2000) |
| " If an underlying problem requires long-term immunosuppressive medication, it is wiser to choose cimetidine rather than increasing the steroid dosage to resolve atypical PFAPA." | 1.30 | PFAPA syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis, Adenitis). ( Chen, LC; Huang, JL; Lee, KF; Lee, WI; Lin, SJ; Yang, MH; Yeh, KW, 1999) |
| "Silicosis may affect multiple organ involvement associated with P-ANCA." | 1.30 | [Two cases of silicosis exhibiting MPO-ANCA associated disorder]. ( Arakawa, M; Gejyo, F; Kourakata, H; Miyamura, S; Nakano, M; Saeki, T; Suzuki, E, 1999) |
| "We report 2 uncommon cases of skin panniculitis (Pa) occurring during the course of relapsing polychondritis (RP)." | 1.29 | Cutaneous panniculitis and relapsing polychondritis: two cases. ( Andrac, L; Bracco, J; Disdier, P; Fuzibet, JG; Harlé, JR; Swiader, L; Veit, V; Weiller, PJ; Weiller-Merli, C, 1996) |
| "Patients with arteritis (n = 106) were studied and divided into five groups." | 1.29 | The diagnosis and management of arteritis. ( Cawthorn, SJ; Giddings, AE; Karanjia, ND, 1993) |
| "A 47-year-old woman affected by systemic lupus erythematosus (SLE) presented with headache, fever, splenomegaly and edema of the lower extremities." | 1.29 | Unusual neuroradiological findings in systemic lupus erythematosus. ( Hinoshita, H; Ono, K; Shiigai, T; Shintani, S; Tsuruoka, S, 1993) |
| "'Pauci-immune' glomerulonephritis has been recognized as an important cause of rapidly progressive glomerulonephritis." | 1.28 | 'Pauci-immune' rapidly progressive glomerulonephritis associated with systemic vasculitis. ( Bang, BK; Chang, YS; Han, JY; Kim, SY; Park, IS; Woo, JY; Yoon, SA, 1992) |
| "At autopsy, a DeBakey type 1 aortic dissection was found and the immediate cause of death was found to be cardiac tamponade secondary to rupture of the aortic dissection." | 1.28 | Polyarteritis nodosa with aortic dissection: necrotizing vasculitis of the vasa vasorum. ( Eguchi, K; Iino, T; Ishijima, M; Nagataki, S; Sakai, M; Toriyama, K, 1992) |
| "A 30-year-old woman with mixed connective tissue disease presented with acute abdominal pain and signs of blood loss." | 1.28 | Hemobilia due to vasculitis of the gall bladder in a patient with mixed connective tissue disease. ( Jager, J; Kuipers, EJ; Nikkels, PG; van Leeuwen, MA; van Rijswijk, MH, 1991) |
| "We describe a fatal case of systemic lupus erythematosus (SLE) developing cerebral and systemic necrotizing vasculitis during pregnancy." | 1.28 | Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus. ( Fukuda, J; Kitagawa, Y; Matsuoka, Y; Mizushima, Y; Suzuki, Y, 1990) |
| "A 46-year-old woman with polyarteritis nodosa and chronic renal failure developed sudden loss of vision which was associated with orbital vasculitis." | 1.27 | Visual recovery in orbital vasculitis. ( Bagegni, A; Douglas, JF; Johnston, PB; Lyness, RW, 1988) |
| "A patient with ulcerative colitis presenting with vasculitic purpura is reported." | 1.27 | A case of ulcerative colitis presenting as vasculitic purpura. ( McCarthy, CF; McDermott, V, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (7.42) | 18.7374 |
| 1990's | 73 (28.52) | 18.2507 |
| 2000's | 94 (36.72) | 29.6817 |
| 2010's | 48 (18.75) | 24.3611 |
| 2020's | 22 (8.59) | 2.80 |
| Authors | Studies |
|---|---|
| Nepal, SP | 1 |
| Nakasato, T | 1 |
| Fukagai, T | 1 |
| Shichijo, T | 1 |
| Morita, J | 1 |
| Maeda, Y | 1 |
| Oshinomi, K | 1 |
| Nakagami, Y | 1 |
| Unoki, T | 1 |
| Noguchi, T | 1 |
| Inoue, T | 1 |
| Kato, R | 1 |
| Amano, S | 1 |
| Mizunuma, M | 1 |
| Kurokawa, M | 1 |
| Tsunokawa, Y | 1 |
| Yasuda, S | 1 |
| Ogawa, Y | 1 |
| Yim, SK | 1 |
| Seo, SY | 1 |
| Ito, C | 1 |
| Odajima, K | 1 |
| Niimura, Y | 1 |
| Fujii, M | 1 |
| Sone, M | 1 |
| Asakawa, S | 1 |
| Arai, S | 1 |
| Yamazaki, O | 1 |
| Tamura, Y | 1 |
| Saito, K | 2 |
| Tada, Y | 1 |
| Yamamoto, T | 2 |
| Kozuma, K | 1 |
| Shibata, S | 1 |
| Fujigaki, Y | 1 |
| Witt, AM | 1 |
| Kodal, LS | 1 |
| Pedersen, BS | 1 |
| Lund, EL | 1 |
| Dysgaard, T | 1 |
| Matsumoto, M | 2 |
| Takakura, H | 1 |
| Usui, Y | 1 |
| Sugimoto, T | 3 |
| Yabe, M | 1 |
| Misaki, K | 1 |
| Kawaguchi, K | 1 |
| Kano, Y | 1 |
| Kato, H | 1 |
| Koike, H | 1 |
| Katsuno, M | 1 |
| Oguri, T | 1 |
| Yuasa, H | 1 |
| Wright, N | 1 |
| Voshtina, E | 1 |
| George, G | 1 |
| Singavi, A | 1 |
| Field, J | 1 |
| Yamauchi, N | 1 |
| Iwamuro, M | 1 |
| Kawano, S | 1 |
| Yamazaki, T | 1 |
| Baba, Y | 2 |
| Tsumura, T | 1 |
| Hara, Y | 1 |
| Kataoka, J | 1 |
| Toyokawa, T | 1 |
| Okada, H | 1 |
| Ahmed, A | 1 |
| Yein, K | 1 |
| Price, E | 1 |
| Horai, Y | 1 |
| Ishikawa, H | 1 |
| Iwanaga, N | 1 |
| Izumi, Y | 1 |
| Matsuoka, Y | 2 |
| Miura, S | 1 |
| Kawakami, A | 1 |
| Kinno, R | 1 |
| Osakabe, Y | 1 |
| Takahashi, S | 1 |
| Kurokawa, S | 1 |
| Owan, Y | 1 |
| Ono, K | 2 |
| Chen, KR | 1 |
| Schmidt, WA | 1 |
| Selvaskandan, H | 1 |
| Kay Cheung, C | 1 |
| Dormer, J | 1 |
| Wimbury, D | 1 |
| Martinez, M | 1 |
| Xu, G | 1 |
| Barratt, J | 1 |
| Lin, TL | 1 |
| Yang, CS | 1 |
| Chen, YJ | 1 |
| Kamoi, K | 1 |
| Kato, S | 1 |
| Uchimaru, K | 1 |
| Tojo, A | 1 |
| Ohno-Matsui, K | 1 |
| Xu, X | 1 |
| Li, X | 1 |
| Pradhan, S | 1 |
| Li, W | 1 |
| Bostan, E | 1 |
| Akdogan, N | 1 |
| Gokoz, O | 1 |
| Dogan, S | 1 |
| Schenker, HM | 1 |
| Hagen, M | 1 |
| Simon, D | 1 |
| Schett, G | 1 |
| Manger, B | 1 |
| Gupta, S | 2 |
| Xu, D | 1 |
| Hadfield, J | 1 |
| Prentice, D | 1 |
| Matsuda, KM | 1 |
| Yoshizaki, A | 1 |
| Kotani, H | 1 |
| Kuzumi, A | 1 |
| Fukayama, M | 1 |
| Ebata, S | 1 |
| Fukasawa, T | 1 |
| Yoshizaki-Ogawa, A | 1 |
| Sato, S | 1 |
| Ueno, K | 1 |
| Nomura, Y | 1 |
| Morita, Y | 1 |
| Kawano, Y | 1 |
| Hasegawa, T | 1 |
| Nagae, S | 1 |
| Taguchi, H | 1 |
| Kirino, Y | 1 |
| Takase-Minegishi, K | 1 |
| Tsuchida, N | 1 |
| Hirahara, L | 1 |
| Kunishita, Y | 1 |
| Yoshimi, R | 1 |
| Nakajima, H | 3 |
| Goliasch, G | 1 |
| Hoke, M | 1 |
| Kawazoe, M | 1 |
| Kaneko, K | 1 |
| Shikano, K | 1 |
| Kusunoki, N | 1 |
| Nanki, T | 1 |
| Kawai, S | 2 |
| Emamifar, A | 1 |
| Hess, S | 1 |
| Gerke, O | 1 |
| Hermann, AP | 1 |
| Laustrup, H | 1 |
| Hansen, PS | 1 |
| Thye-Rønn, P | 1 |
| Marcussen, N | 1 |
| Svendstrup, F | 1 |
| Gildberg-Mortensen, R | 1 |
| Bang, JC | 1 |
| Farahani, ZA | 1 |
| Chrysidis, S | 1 |
| Toftegaard, P | 1 |
| Andreasen, RA | 1 |
| le Greves, S | 1 |
| Andersen, HR | 1 |
| Olsen, RN | 1 |
| Hansen, IMJ | 1 |
| Gravito-Soares, E | 1 |
| Gravito-Soares, M | 1 |
| Cipriano, MA | 1 |
| Amaro, P | 1 |
| Bando, K | 1 |
| Maeba, H | 1 |
| Shiojima, I | 1 |
| Kondo, T | 1 |
| Ohira, Y | 1 |
| Uehara, T | 1 |
| Noda, K | 1 |
| Tsukamoto, T | 1 |
| Ikusaka, M | 1 |
| Kakehi, E | 1 |
| Adachi, S | 1 |
| Fukuyasu, Y | 1 |
| Hashimoto, Y | 1 |
| Yoshida, M | 2 |
| Osaka, T | 1 |
| Hirotani, A | 1 |
| Danbara, H | 1 |
| Shimizu, K | 1 |
| Fujita, R | 1 |
| Kotani, K | 1 |
| Matsumura, M | 3 |
| Horino, T | 2 |
| Hamada-Ode, K | 1 |
| Ichii, O | 1 |
| Terada, Y | 2 |
| Asseri, AA | 1 |
| Zeng, Y | 1 |
| Daines, CL | 1 |
| Wilkos-Kuc, A | 1 |
| Biziorek, B | 1 |
| Zarnowski, T | 1 |
| Fuse, Y | 1 |
| Haubitz, M | 2 |
| Ashida, A | 1 |
| Murata, H | 1 |
| Ohashi, A | 1 |
| Ogawa, E | 1 |
| Uhara, H | 1 |
| Okuyama, R | 1 |
| Yates, M | 1 |
| Loke, YK | 1 |
| Watts, RA | 1 |
| MacGregor, AJ | 1 |
| Kim, SH | 1 |
| Park, J | 1 |
| Bae, JH | 1 |
| Cho, MS | 1 |
| Park, KD | 1 |
| Jeong, JH | 1 |
| Boules, E | 1 |
| Lyon, C | 1 |
| Kanda, T | 1 |
| Kanzawa, Y | 1 |
| Imai, Y | 1 |
| Mizuno, Y | 1 |
| Nishioka, H | 1 |
| Takahashi, H | 1 |
| Tsuboi, H | 1 |
| Abe, S | 1 |
| Yokosawa, M | 1 |
| Hagiwara, S | 1 |
| Asashima, H | 1 |
| Hirota, T | 1 |
| Umeda, N | 1 |
| Kondo, Y | 1 |
| Matsumoto, I | 1 |
| Sumida, T | 1 |
| Gattimallanahali, Y | 1 |
| Mangat, G | 1 |
| Canchi, B | 1 |
| Kakade, G | 1 |
| Nanbu, A | 1 |
| Sugiura, K | 1 |
| Sassa, N | 1 |
| Akiyama, M | 1 |
| Kamiya, M | 1 |
| Shane, PY | 1 |
| Soejima, M | 1 |
| Tohda, S | 1 |
| Miyasaka, N | 1 |
| Kohsaka, H | 1 |
| Kano, K | 1 |
| Katayama, T | 1 |
| Takeguchi, S | 1 |
| Asanome, A | 1 |
| Takahashi, K | 2 |
| Saito, T | 1 |
| Sawada, J | 1 |
| Saito, M | 1 |
| Anei, R | 1 |
| Kamada, K | 1 |
| Miyokawa, N | 1 |
| Nishihara, H | 1 |
| Hasebe, N | 1 |
| Higashihara, T | 1 |
| Okada, A | 1 |
| Kusano, T | 1 |
| Ishigaki, K | 1 |
| Shimizu, A | 1 |
| Takano, H | 1 |
| Bakashvili, N | 1 |
| Swaak, AJ | 1 |
| Tervaert, JW | 6 |
| Dees, A | 1 |
| Canpolat, N | 1 |
| Topal, N | 1 |
| Civilibal, M | 1 |
| Caliskan, S | 1 |
| Sever, L | 1 |
| Kasapcopur, O | 1 |
| Baserer, T | 1 |
| Arisoy, N | 1 |
| Gupta, A | 1 |
| Gupta, G | 1 |
| Marouf, R | 1 |
| Iriyama, T | 1 |
| Horikoshi, E | 1 |
| Sawada, S | 1 |
| Hayashi, K | 1 |
| Takeuchi, H | 1 |
| Kono, H | 1 |
| Ikewaki, J | 1 |
| Kimoto, K | 1 |
| Furushima, M | 1 |
| Yae, Y | 1 |
| Shinoda, K | 1 |
| Nakatsuka, K | 1 |
| Joshi, L | 1 |
| Hamour, S | 1 |
| Salama, AD | 1 |
| Pusey, CD | 5 |
| Lightman, S | 1 |
| Taylor, SR | 1 |
| Kishore, D | 1 |
| Misra, S | 1 |
| Tokunaga, M | 1 |
| Tamura, M | 1 |
| Kabashima, N | 1 |
| Serino, R | 1 |
| Shibata, T | 2 |
| Miyamoto, T | 1 |
| Miyazaki, M | 1 |
| Furuno, Y | 1 |
| Fujimatsu, S | 1 |
| Muta, T | 1 |
| Takeuchi, M | 1 |
| Abe, H | 1 |
| Okazaki, M | 1 |
| Otsuji, Y | 1 |
| de Groot, K | 5 |
| Harper, L | 2 |
| Jayne, DR | 4 |
| Flores Suarez, LF | 1 |
| Gregorini, G | 3 |
| Gross, WL | 4 |
| Luqmani, R | 3 |
| Rasmussen, N | 3 |
| Sinico, RA | 1 |
| Tesar, V | 2 |
| Vanhille, P | 1 |
| Westman, K | 2 |
| Savage, CO | 2 |
| Turnbull, J | 1 |
| Nakabayashi, K | 2 |
| Arimura, Y | 3 |
| Yoshihara, K | 1 |
| Fukuoka, T | 2 |
| Karube, M | 1 |
| Yamato, T | 1 |
| Koji, H | 1 |
| Ikegaya, N | 1 |
| Ohtuka, T | 1 |
| Kawashima, S | 1 |
| Sudo, M | 1 |
| Yamada, A | 2 |
| Kötter, I | 2 |
| Takao, T | 1 |
| Taniguchi, Y | 2 |
| Ashikaga, E | 1 |
| Iyoda, M | 1 |
| Suzuki, H | 1 |
| Nagai, H | 2 |
| Akizawa, T | 1 |
| Saruwatari, H | 1 |
| Yoshifuku, A | 1 |
| Kawai, K | 1 |
| Kanekura, T | 1 |
| Riksen, NP | 1 |
| Gehlmann, H | 1 |
| Brouwer, AE | 1 |
| van Deuren, M | 1 |
| Lui, NL | 1 |
| Thumboo, J | 1 |
| Fong, KY | 1 |
| Deuter, C | 1 |
| Caltik, A | 1 |
| Demircin, G | 1 |
| Bülbül, M | 1 |
| Erdogan, O | 1 |
| Akyüz, SG | 1 |
| Arda, N | 1 |
| Hirohama, D | 1 |
| Hoshino, J | 1 |
| Hasegawa, E | 1 |
| Yamanouchi, M | 1 |
| Hayami, N | 1 |
| Suwabe, T | 1 |
| Sawa, N | 1 |
| Takemoto, F | 1 |
| Ubara, Y | 1 |
| Hara, S | 1 |
| Ohashi, K | 1 |
| Takaichi, K | 1 |
| Ko, JH | 1 |
| Shih, YC | 1 |
| Hui, RC | 1 |
| Yang, CH | 1 |
| Rozin, AP | 1 |
| Egozi, D | 1 |
| Ramon, Y | 1 |
| Toledano, K | 1 |
| Braun-Moscovici, Y | 1 |
| Markovits, D | 1 |
| Schapira, D | 1 |
| Bergman, R | 1 |
| Melamed, Y | 1 |
| Ullman, Y | 1 |
| Balbir-Gurman, A | 1 |
| Tayal, V | 1 |
| Chiu, YH | 1 |
| George, E | 1 |
| Mane, S | 1 |
| Hasiloglu, ZI | 1 |
| Albayram, S | 1 |
| Tasmali, K | 1 |
| Erer, B | 1 |
| Selcuk, H | 1 |
| Islak, C | 1 |
| Beccastrini, E | 1 |
| Emmi, G | 1 |
| Squatrito, D | 1 |
| Nesi, G | 1 |
| Almerigogna, F | 1 |
| Emmi, L | 1 |
| Lee, MY | 1 |
| Kim, HH | 1 |
| Kim, KS | 1 |
| Fujioka, Y | 1 |
| Marumo, T | 1 |
| Umino, M | 1 |
| Kamiya, Y | 1 |
| Okai, T | 1 |
| Tsurumaki, S | 1 |
| Nagasawa, T | 2 |
| Rasalkar, DD | 1 |
| Paunipagar, BK | 1 |
| Watanabe, H | 2 |
| Hirase, N | 1 |
| Goda, H | 1 |
| Nishikawa, H | 1 |
| Ikuyama, S | 1 |
| Tian, G | 1 |
| Lu, N | 1 |
| Yan, R | 1 |
| Zhang, X | 1 |
| Vivekananda, U | 1 |
| Hirsch, NP | 1 |
| Kullmann, DM | 1 |
| Alvarez, D | 1 |
| Phadke, R | 1 |
| Howard, RS | 1 |
| Wada, T | 1 |
| Hara, A | 1 |
| Sada, KE | 1 |
| Makino, H | 1 |
| Kieu, V | 1 |
| Williams, R | 1 |
| Hill, P | 1 |
| Kelly, R | 1 |
| Hong, JY | 1 |
| Lai, CC | 1 |
| Chang, YS | 2 |
| Hsiao, KH | 1 |
| Chou, CT | 1 |
| Chen, WS | 1 |
| Li, R | 1 |
| Chen, Z | 1 |
| Dogra, S | 1 |
| Suri, D | 1 |
| Shah, R | 1 |
| Rawat, A | 1 |
| Singh, S | 2 |
| Sodhi, KS | 1 |
| Sarui, H | 1 |
| Sano, A | 1 |
| Maruyama, T | 1 |
| Nakashima, K | 1 |
| Takeda, N | 1 |
| Yasuda, K | 1 |
| Saatci, OA | 1 |
| Koçak, N | 1 |
| Durak, I | 1 |
| Ergin, MH | 1 |
| Rodriguez, N | 1 |
| Eliott, D | 1 |
| Garcia-Valenzuela, E | 1 |
| Baker, J | 1 |
| Jaing, TH | 1 |
| Hsueh, C | 1 |
| Chiu, CH | 1 |
| Shih, IH | 1 |
| Chan, CK | 1 |
| Hung, IJ | 1 |
| Manz, B | 1 |
| Rytter, M | 1 |
| Mittag, M | 1 |
| Seidel, W | 1 |
| Nenoff, P | 1 |
| Hasegawa, M | 1 |
| Kawamura, N | 1 |
| Kasugai, M | 1 |
| Koide, S | 1 |
| Murase, M | 1 |
| Asano, S | 1 |
| Toba, T | 1 |
| Kushimoto, H | 1 |
| Murakami, K | 2 |
| Tomita, M | 1 |
| Shikano, M | 1 |
| Sugiyama, S | 1 |
| Arbach, O | 1 |
| Gause, A | 2 |
| Schneider, U | 1 |
| Inhoffen, W | 1 |
| Gelisken, F | 1 |
| Jayne, D | 2 |
| Andrassy, K | 1 |
| Bacon, P | 2 |
| Dadoniené, J | 1 |
| Ekstrand, A | 1 |
| Gaskin, G | 3 |
| Gross, W | 1 |
| Hagen, EC | 1 |
| Mirapeix, E | 1 |
| Pettersson, E | 1 |
| Siegert, C | 1 |
| Sinico, A | 1 |
| Pusey, C | 1 |
| DVORSZKY, K | 2 |
| CSEPLAK, G | 2 |
| Sisk, CM | 1 |
| Parker, C | 1 |
| Cassidy, T | 1 |
| Parker, A | 1 |
| Stegeman, CA | 3 |
| Inoue, K | 1 |
| Kumagai, C | 1 |
| Nishioka, T | 1 |
| Osaki, F | 1 |
| Kumon, Y | 1 |
| Suehiro, T | 1 |
| Hashimoto, K | 1 |
| Arisawa, T | 1 |
| Chen, SI | 1 |
| Sahni, J | 1 |
| Hart, IK | 1 |
| Booth, AD | 1 |
| Kharbanda, RK | 1 |
| McEniery, CM | 1 |
| Mackenzie, IS | 1 |
| Brown, J | 1 |
| Wilkinson, IB | 1 |
| Yamashita, M | 1 |
| Funayama, H | 1 |
| Anami, Y | 1 |
| Morikawa, N | 1 |
| Inokuma, S | 1 |
| Ang, A | 1 |
| Galloway, G | 1 |
| Kashkouli, MB | 1 |
| Beigi, B | 1 |
| Dass, R | 1 |
| Ramesh, P | 1 |
| Ratho, RK | 1 |
| Saxena, AK | 1 |
| Manoharan, S | 1 |
| Muir, J | 1 |
| Mayer, DF | 1 |
| Matteson, EL | 1 |
| Ogawa, H | 1 |
| Nishi, E | 1 |
| Kameda, H | 1 |
| Amano, K | 1 |
| Takeuchi, T | 1 |
| Panani, AD | 1 |
| Grigoriadou, M | 1 |
| Magira, E | 1 |
| Roussos, C | 1 |
| Raptis, SA | 1 |
| Eriksson, P | 1 |
| Hashimoto, H | 3 |
| Bacon, PA | 3 |
| Feighery, C | 1 |
| Shio, K | 1 |
| Kobayashi, H | 1 |
| Ikeda, T | 1 |
| Fukaya, E | 1 |
| Iwadate, H | 1 |
| Hikichi, T | 1 |
| Sekine, H | 1 |
| Obara, K | 1 |
| Sato, Y | 1 |
| Shikama, Y | 1 |
| Kuriu, K | 1 |
| Shibuya, Y | 1 |
| Matsuda, M | 1 |
| Omayu, S | 1 |
| Kamio, Y | 1 |
| Kitami, A | 1 |
| Kasahara, K | 1 |
| Kadokura, M | 1 |
| Kinugasa, E | 1 |
| Sanders, JS | 1 |
| Huitma, MG | 1 |
| Kallenberg, CG | 2 |
| Hamaguchi, M | 1 |
| Kawahito, Y | 1 |
| Tsubouchi, Y | 1 |
| Kohno, M | 2 |
| Yamamoto, A | 1 |
| Ishino, H | 1 |
| Wada, M | 1 |
| Yoshikawa, T | 1 |
| Hirano, T | 1 |
| Fukushima, H | 1 |
| Sasaki, Y | 1 |
| Yoshikawa, N | 1 |
| Oka, K | 1 |
| Tosun, A | 1 |
| Serdaroğlu, G | 1 |
| Aslan, MT | 1 |
| Polat, M | 1 |
| Akalin, T | 1 |
| Tekgul, H | 1 |
| Gökben, S | 1 |
| Hu, ZM | 1 |
| Wang, HB | 1 |
| Zhou, MQ | 1 |
| Yao, XS | 1 |
| Ma, L | 1 |
| Wang, XN | 1 |
| Ghosh, JB | 1 |
| Gupta, D | 1 |
| Chattopadhyay, N | 1 |
| Sakaguchi, M | 1 |
| Deji, N | 1 |
| Uzu, T | 1 |
| Nishio, Y | 1 |
| Kashiwagi, A | 2 |
| Kuttikat, A | 1 |
| Keat, A | 1 |
| Hughes, R | 1 |
| Hakim, A | 1 |
| Chakravarty, K | 1 |
| Stassen, PM | 1 |
| Naumann, UK | 1 |
| Krayenbühl, PA | 1 |
| Steurer-Stey, C | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Alizadeh, H | 1 |
| Kristenssen, J | 1 |
| El Teraifi, H | 1 |
| Malanin, K | 1 |
| Kuboshima, S | 1 |
| Tsuruoka, K | 1 |
| Shirai, S | 1 |
| Sasaki, H | 1 |
| Sakurada, T | 1 |
| Miura, H | 2 |
| Okabayashi, J | 1 |
| Konno, Y | 1 |
| Shima, Y | 1 |
| Yasuda, T | 1 |
| Sato, T | 3 |
| Kimura, K | 1 |
| Yakushiji, Y | 1 |
| Mizuta, H | 1 |
| Kurohara, K | 1 |
| Onoue, H | 1 |
| Okada, R | 1 |
| Yoshimura, T | 1 |
| Kuroda, Y | 1 |
| Lee, JS | 1 |
| Loh, TH | 1 |
| Seow, SC | 1 |
| Tan, SH | 1 |
| Yoshioka, K | 1 |
| Hattori, T | 1 |
| Isaka, Y | 1 |
| Yamaguchi, T | 1 |
| Yamagami, K | 1 |
| Morikawa, T | 1 |
| Konishi, Y | 1 |
| Imanishi, M | 1 |
| Kumar, N | 1 |
| Choudhary, N | 1 |
| Agarwal, G | 1 |
| Rizvi, Y | 1 |
| Kaul, B | 1 |
| Ahlawat, R | 1 |
| Mazzocchi, O | 1 |
| Risso, JA | 1 |
| Viozzi, F | 1 |
| Apa, NP | 1 |
| Peralba, MC | 1 |
| Nadal, MA | 1 |
| De Rosa, GE | 1 |
| Hajiro, T | 1 |
| Fujimoto, T | 1 |
| Kojyo, N | 1 |
| Horie, M | 1 |
| Ozaki, S | 1 |
| Solans-Laqué, R | 1 |
| Bosch-Gil, JA | 1 |
| Pérez-Bocanegra, C | 1 |
| Selva-O'Callaghan, A | 1 |
| Simeón-Aznar, CP | 1 |
| Vilardell-Tarres, M | 1 |
| von Bierbrauer, A | 1 |
| Pelzer, C | 1 |
| Fischer, V | 1 |
| Yalçindağ, FN | 1 |
| Amer, R | 1 |
| Forrester, JV | 1 |
| Alekhin, DI | 1 |
| Fokin, AA | 1 |
| Mikhaĭlova, OA | 1 |
| Sumnaia, DB | 1 |
| Goloshchapova, ZhA | 1 |
| Cansu, D | 1 |
| Kaşifoğlu, T | 1 |
| Paşaoğlu, O | 1 |
| Korkmaz, C | 2 |
| Katsantonis, JC | 1 |
| Protopsaltis, J | 1 |
| Kokkoris, S | 1 |
| Brestas, P | 1 |
| Aroni, K | 1 |
| Tournis, S | 1 |
| Giannoulis, G | 1 |
| Hughes, RA | 1 |
| Cameron, JS | 2 |
| Hall, SM | 1 |
| Heaton, J | 1 |
| Payan, J | 1 |
| Teoh, R | 1 |
| Barratt, TM | 1 |
| Geary, DF | 1 |
| Yu, YJ | 1 |
| Cooper, DR | 1 |
| Wellenstein, DE | 1 |
| Block, B | 1 |
| Hodson, ME | 1 |
| Haslam, PL | 1 |
| Spiro, SG | 1 |
| Turner-Warwick, M | 1 |
| Luderschmidt, C | 1 |
| Gutschow, K | 1 |
| Baumeister, RG | 1 |
| Albrich, W | 1 |
| Eiermann, W | 1 |
| Parameswaran, K | 1 |
| Keaney, NP | 1 |
| Veale, D | 1 |
| Inoh, M | 1 |
| Tokuda, M | 1 |
| Maruoka, T | 1 |
| Kinashi, M | 1 |
| Kurata, N | 1 |
| Okawa, M | 1 |
| Takahara, J | 1 |
| Shintani, S | 2 |
| Tsuruoka, S | 2 |
| Yamada, M | 1 |
| Ozawa, T | 1 |
| Sasaki, O | 1 |
| Sorimachi, T | 1 |
| Tanaka, R | 1 |
| Ishikura, T | 1 |
| Horikiri, H | 1 |
| Umehara, F | 1 |
| Nakahara, K | 1 |
| Goto, T | 1 |
| Higuchi, I | 1 |
| Nakagawa, M | 1 |
| Maruyama, I | 1 |
| Osame, M | 1 |
| Howe, LJ | 1 |
| Stanford, MR | 3 |
| Edelsten, C | 1 |
| Graham, EM | 3 |
| De'Oliviera, J | 2 |
| Dash, A | 2 |
| Rees, AJ | 3 |
| Gordon, M | 1 |
| Luqmani, RA | 2 |
| Adu, D | 3 |
| Greaves, I | 1 |
| Richards, N | 1 |
| Michael, J | 2 |
| Emery, P | 4 |
| Howie, AJ | 2 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Saita, N | 1 |
| Asahara, K | 1 |
| Kohrogi, H | 1 |
| Sakata, T | 1 |
| Suga, M | 1 |
| Ando, M | 1 |
| Navarro, JF | 1 |
| Quereda, C | 1 |
| Rivera, M | 1 |
| Navarro, FJ | 1 |
| Ortuño, J | 1 |
| Wynn, RF | 1 |
| Laing, RB | 1 |
| Leen, CL | 1 |
| Statham, P | 1 |
| Emmanuel, FX | 1 |
| Karanjia, ND | 1 |
| Cawthorn, SJ | 1 |
| Giddings, AE | 1 |
| Yasuda, Y | 2 |
| Matsuda, I | 2 |
| Kang, Y | 2 |
| Saiga, T | 2 |
| Kameyama, M | 2 |
| Hamuryudan, V | 1 |
| Yurdakul, S | 1 |
| Moral, F | 1 |
| Numan, F | 1 |
| Tüzün, H | 1 |
| Tüzüner, N | 1 |
| Mat, C | 1 |
| Tüzün, Y | 1 |
| Ozyazgan, Y | 1 |
| Yazïci, H | 1 |
| Iida, N | 1 |
| Murata, D | 1 |
| Sugimoto, M | 1 |
| Hirose, S | 1 |
| Gerraty, RP | 1 |
| McKelvie, PA | 1 |
| Byrne, E | 1 |
| Erlendsson, K | 1 |
| Steinsson, K | 1 |
| Jóhannsson, JH | 1 |
| Geirsson, RT | 1 |
| Schellong, MS | 1 |
| Niedermeyer, J | 1 |
| Bernhards, J | 1 |
| Fabel, H | 1 |
| Alexander, K | 1 |
| Berlit, P | 1 |
| Härle, M | 1 |
| Buss, J | 1 |
| Klötzsch, C | 1 |
| Lockwood, CM | 1 |
| Delpla, PA | 1 |
| Delisle, MB | 1 |
| Arné-Bès, MC | 1 |
| Archambaud, M | 1 |
| Géraud, G | 1 |
| Bès, A | 1 |
| Hirohata, S | 1 |
| Tanimoto, K | 1 |
| Ito, K | 1 |
| Hinoshita, H | 1 |
| Shiigai, T | 1 |
| Iijima, S | 1 |
| Takita, T | 1 |
| Otsuka, F | 1 |
| Kashiwamura, H | 1 |
| Oyama, Y | 1 |
| Itoh, J | 1 |
| Bergink, GJ | 1 |
| Ooyman, FM | 1 |
| Maas, S | 1 |
| Rademakers, AJ | 1 |
| Lambert, M | 1 |
| Weber, A | 1 |
| Boland, B | 1 |
| De Plaen, JF | 1 |
| Donckier, J | 1 |
| Watson, I | 1 |
| Hill, CM | 1 |
| Biggart, JD | 1 |
| Russell, CJ | 1 |
| Garrett, PJ | 2 |
| Palmer, HE | 2 |
| Zaman, AG | 1 |
| Ellis, BA | 1 |
| Wallace, GR | 2 |
| Le Mao, G | 1 |
| Rostaing, L | 1 |
| Modesto, A | 1 |
| Oksman, F | 1 |
| Cisterne, JM | 1 |
| Durand, D | 1 |
| Biswas, J | 1 |
| Fogla, R | 1 |
| Madhavan, HN | 1 |
| Parry, R | 1 |
| Sherwin, S | 1 |
| Fletcher, V | 1 |
| Medcalf, P | 1 |
| Disdier, P | 1 |
| Andrac, L | 1 |
| Swiader, L | 1 |
| Veit, V | 1 |
| Fuzibet, JG | 1 |
| Weiller-Merli, C | 1 |
| Bracco, J | 1 |
| Harlé, JR | 1 |
| Weiller, PJ | 1 |
| Chandran, G | 1 |
| Ahern, MJ | 1 |
| Seshadri, P | 1 |
| Coghlan, D | 1 |
| Konishi, M | 1 |
| Ohosone, Y | 1 |
| Oyamada, Y | 1 |
| Yamaguchi, K | 1 |
| Kawahara, Y | 1 |
| Mimori, T | 1 |
| Ikeda, Y | 1 |
| Salminen, A | 1 |
| Suhonen, R | 1 |
| Vänttinen, T | 1 |
| Heckmann, JG | 1 |
| Engelhardt, A | 1 |
| Druschky, A | 1 |
| Blum, HE | 1 |
| Neundörfer, B | 1 |
| Espino-Montoro, A | 1 |
| Medina, M | 1 |
| Marin-Martin, J | 1 |
| Jimenez-Gonzalo, FJ | 1 |
| Moalla, AK | 1 |
| Fernandez-Gonzalez, G | 1 |
| Vahi, R | 1 |
| Pall, A | 1 |
| Richards, NT | 1 |
| Rechichi, CF | 1 |
| Trombetta, C | 1 |
| Scullica, MG | 1 |
| Tripodi, G | 1 |
| Quattrocchi, E | 1 |
| Ferreri, G | 1 |
| Gran, JT | 1 |
| Shimizu, T | 1 |
| Kagawa, H | 1 |
| Katsura, K | 1 |
| Shirai, K | 1 |
| Yamanaka, Y | 1 |
| Kishimoto, Y | 1 |
| Okamura, A | 1 |
| Fukuhara, S | 1 |
| Schulzeck, P | 1 |
| Schellong, S | 1 |
| Schulze, M | 1 |
| Koch, KM | 1 |
| Brunkhorst, R | 1 |
| Nishitsuji, M | 1 |
| Nakamura, H | 1 |
| Fujimura, M | 1 |
| Matsuda, T | 1 |
| Miyamoto, D | 1 |
| Ichinose, Y | 1 |
| Kikawada, M | 1 |
| Kusumoto, H | 1 |
| Yanagisawa, N | 1 |
| Kanai, E | 1 |
| Minemura, K | 1 |
| Yonemaru, M | 1 |
| Toyama, K | 1 |
| Hafeez, ZH | 1 |
| Efe, B | 1 |
| Tel, N | 1 |
| Kabukçuoglu, S | 1 |
| Erenoglu, E | 1 |
| Hennebry, TA | 1 |
| Mann, JJ | 1 |
| Hellmann, DB | 1 |
| Ikeda, M | 1 |
| Yamamoto, Y | 1 |
| Kodama, H | 1 |
| Ysasaga, JE | 1 |
| Davis, J | 1 |
| Lowy, C | 1 |
| Wheeler, MJ | 1 |
| Gatenby, PA | 1 |
| Kourakata, H | 1 |
| Saeki, T | 2 |
| Miyamura, S | 2 |
| Suzuki, E | 1 |
| Nakano, M | 1 |
| Gejyo, F | 1 |
| Arakawa, M | 2 |
| Nagahama, T | 1 |
| Matsui, T | 1 |
| Matake, H | 1 |
| Tsuda, S | 1 |
| Sakurai, T | 1 |
| Yao, T | 1 |
| Schlemper, R | 1 |
| Yoshida, A | 1 |
| Takeda, A | 1 |
| Fukuda, M | 1 |
| Toda, S | 1 |
| Morozumi, K | 1 |
| Bohgaki, T | 1 |
| Mukai, M | 1 |
| Notoya, A | 1 |
| Matsubara, K | 1 |
| Nigami, H | 1 |
| Harigaya, H | 1 |
| Osaki, M | 1 |
| Baba, K | 1 |
| Katae, M | 1 |
| Noto, K | 1 |
| Suzuki, T | 2 |
| Dambara, T | 1 |
| Fukuchi, Y | 1 |
| Lamprecht, P | 1 |
| Borman, P | 1 |
| Bodur, H | 1 |
| Güleç, AT | 1 |
| Uçan, H | 1 |
| Seçkin, U | 1 |
| Mocan, G | 1 |
| Ramchandani, M | 1 |
| Brown, AM | 1 |
| Rippin, JW | 1 |
| Murray, PI | 1 |
| Salmon, JF | 1 |
| Ursell, PG | 1 |
| Frith, P | 1 |
| Masuyama, J | 1 |
| Deshpande, PV | 1 |
| Gilbert, R | 1 |
| Alton, H | 1 |
| Milford, DV | 1 |
| Van Doornum, S | 1 |
| McColl, G | 1 |
| Walter, M | 1 |
| Jennens, I | 1 |
| Bhathal, P | 1 |
| Wicks, IP | 1 |
| Lee, WI | 1 |
| Yang, MH | 1 |
| Lee, KF | 1 |
| Chen, LC | 1 |
| Lin, SJ | 1 |
| Yeh, KW | 1 |
| Huang, JL | 1 |
| Takeuchi, K | 1 |
| Yamanishi, Y | 1 |
| Ishioka, S | 1 |
| Yamakido, M | 1 |
| Handa, R | 1 |
| Wali, JP | 1 |
| Gupta, SD | 1 |
| Dinda, AK | 1 |
| Aggarwal, P | 1 |
| Wig, N | 1 |
| Biswas, A | 1 |
| Ueno, M | 1 |
| Shimada, H | 2 |
| Nishi, S | 1 |
| Imai, N | 1 |
| Gejou, F | 1 |
| Komdeur, R | 1 |
| Zijlstra, JG | 1 |
| van der Werf, TS | 1 |
| Ligtenberg, JJ | 1 |
| Tulleken, JE | 1 |
| Carruthers, D | 1 |
| Marzo-Ortega, H | 1 |
| McGonagle, D | 1 |
| O'Connor, P | 1 |
| Pease, C | 1 |
| Day, C | 1 |
| Savage, C | 1 |
| Morita, A | 1 |
| Tsuji, T | 1 |
| Ribbens, C | 1 |
| Martin y Porras, M | 1 |
| Franchimont, N | 1 |
| Kaiser, MJ | 1 |
| Jaspar, JM | 1 |
| Damas, P | 1 |
| Houssiau, FA | 1 |
| Malaise, MG | 1 |
| Wang, IJ | 1 |
| Hsu, WM | 1 |
| Shun, CT | 1 |
| Chiang, BL | 1 |
| Ni, YH | 1 |
| Kageyama, Y | 1 |
| Yagi, T | 1 |
| Miyairi, M | 1 |
| Böcher, W | 1 |
| Galle, PR | 1 |
| Märker-Hermann, E | 1 |
| Loddenkemper, K | 1 |
| Perka, C | 1 |
| Burmester, GR | 1 |
| Buttgereit, F | 1 |
| Han, JY | 1 |
| Yoon, SA | 1 |
| Woo, JY | 1 |
| Park, IS | 1 |
| Kim, SY | 1 |
| Bang, BK | 1 |
| Dewhurst, AG | 1 |
| Morgan, LS | 1 |
| Mason, JC | 1 |
| Dathan, JR | 1 |
| Saida, K | 1 |
| Iino, T | 1 |
| Eguchi, K | 1 |
| Sakai, M | 1 |
| Nagataki, S | 1 |
| Ishijima, M | 1 |
| Toriyama, K | 1 |
| Kitagaki, K | 1 |
| Miura, T | 1 |
| Shimazawa, T | 1 |
| Koda, A | 1 |
| Klausen, OG | 1 |
| Franzén, G | 1 |
| Berentsen, S | 1 |
| Nakai, A | 1 |
| Saika, S | 1 |
| Harland, CC | 1 |
| Kilby, PE | 1 |
| Frankel, AH | 1 |
| Singer, DR | 1 |
| Winearls, CG | 1 |
| Evans, DJ | 1 |
| Jubb, R | 1 |
| Reid, A | 1 |
| Hayasaka, S | 1 |
| Takatori, Y | 1 |
| Noda, S | 1 |
| Setogawa, T | 1 |
| Hayashi, H | 2 |
| Barlow, RJ | 1 |
| Schulz, EJ | 1 |
| Kuipers, EJ | 1 |
| van Leeuwen, MA | 1 |
| Nikkels, PG | 1 |
| Jager, J | 1 |
| van Rijswijk, MH | 1 |
| Suzuki, Y | 1 |
| Kitagawa, Y | 1 |
| Fukuda, J | 1 |
| Mizushima, Y | 2 |
| Mutimer, DJ | 1 |
| Bassendine, MF | 1 |
| Crook, P | 1 |
| James, OF | 1 |
| Ochiai, T | 1 |
| Sakamoto, K | 1 |
| Gunji, Y | 1 |
| Hamaguchi, K | 1 |
| Isegawa, N | 1 |
| Yasumoto, A | 1 |
| Asano, T | 1 |
| Jain, S | 1 |
| Tayal, A | 1 |
| Bagegni, A | 1 |
| Lyness, RW | 1 |
| Johnston, PB | 1 |
| Douglas, JF | 1 |
| ter Borg, EJ | 1 |
| Hollema, H | 1 |
| de Jong, PE | 1 |
| Kodama, M | 1 |
| Baba, M | 1 |
| Takeuchi, A | 1 |
| Tamura, T | 1 |
| Hashimoto, T | 1 |
| Miyashita, H | 1 |
| Takatsu, M | 1 |
| Toyoda, M | 1 |
| McDermott, V | 1 |
| McCarthy, CF | 1 |
| Bulman, CH | 1 |
| Kane, RJ | 1 |
| Srivastva, VN | 1 |
| Kumar, A | 1 |
| Malaviya, AN | 1 |
| Bhat, A | 1 |
| Misra, R | 1 |
| Banerjee, S | 1 |
| Sindhwani, R | 1 |
| Tiwari, SC | 1 |
| Bhuyan, UN | 1 |
| Guleria, JS | 1 |
| Aikawa, T | 1 |
| Yoshizawa, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides[NCT00430105] | Phase 2/Phase 3 | 160 participants | Interventional | 1998-02-28 | Completed | ||
| Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial[NCT02198248] | Phase 4 | 140 participants (Actual) | Interventional | 2014-10-31 | Active, not recruiting | ||
| Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial[NCT02460588] | Phase 3 | 120 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis[NCT01697267] | Phase 3 | 188 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B-cell Reconstitution vs a Serologic ANCA Flare[NCT02749292] | Phase 4 | 115 participants (Actual) | Interventional | 2016-06-30 | Terminated (stopped due to Due to the coronavirus disease 2019 (COVID-19) pandemic and the deleterious impact of rituximab on vaccination efficacy, the trial was concluded before reaching the target enrollment of 200.) | ||
| Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis[NCT02626845] | Phase 4 | 3 participants (Actual) | Interventional | 2015-12-31 | Terminated (stopped due to Slow recruitment) | ||
| Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.[NCT00751517] | Phase 2 | 0 participants | Interventional | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 12 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 50.8 |
| Azathioprine Maintenance | 51.9 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 24 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 51.9 |
| Azathioprine Maintenance | 53.5 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 36 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 52.3 |
| Azathioprine Maintenance | 51.8 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 4 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 51.8 |
| Azathioprine Maintenance | 51.0 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 48 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 50.9 |
| Azathioprine Maintenance | 53.9 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 12 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 38.2 |
| Azathioprine Maintenance | 34.6 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 24 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 36.7 |
| Azathioprine Maintenance | 35.6 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 36 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 34.6 |
| Azathioprine Maintenance | 33.8 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 4 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 36.7 |
| Azathioprine Maintenance | 36.1 |
The 36-Item Short Form Health Survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. Scores for the scale range from 0-100 and transformed to have a mean of 50 and SD of 10 in the reference population, with higher scores indicating a better Health-related Quality of Life. (NCT01697267)
Timeframe: 48 months
| Intervention | score on a scale (Mean) |
|---|---|
| Rituximab Maintenance | 35.8 |
| Azathioprine Maintenance | 35.0 |
Infection (treated with intravenous or oral antibiotics) rates (NCT01697267)
Timeframe: Up to 4 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Rituximab Maintenance | 54 |
| Azathioprine Maintenance | 62 |
Severe adverse event (SAE) rate (NCT01697267)
Timeframe: Up to 48 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Rituximab Maintenance | 37 |
| Azathioprine Maintenance | 48 |
Cumulative accrual of damage as measured by the combined damage assessment score (CDA). Each persistent or new occurrence of damage is given a score of 1. The cumulative accrual of damage is obtained by summing across the different types of damage to get an overall score (max score = 64). (NCT01697267)
Timeframe: data in Rows represent the change from randomization (month 4) to months 12, 24, 36, and 48.
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Randomisation to month 12 | Randomisation to month 24 | Randomisation to month 36 | Randomisation to month 48 | |
| Azathioprine Maintenance | 0.337 | 0.533 | 0.899 | 1.38 |
| Rituximab Maintenance | 0.275 | 0.571 | 0.676 | 1.09 |
Cumulative glucocorticoid (GC) exposure during the trial. The trial had a common close out date when the final patient reached month 36 in the trial. Patients were followed until month 48 or the common close out date, whichever happened sooner. Therefore, follow up varied between 36 and 48 months. Cumulative glucocorticoid exposure is presented as a dose in mg for during the treatment period (up to month 24) and across the whole trial (until month 48 or common close out when the final patient reached month 36). (NCT01697267)
Timeframe: Up to 48 months
| Intervention | mg (Mean) | |
|---|---|---|
| Overall (randomisation to end of trial) | Maintenance treatment period (randomisation to month 24) | |
| Azathioprine Maintenance | 4780 | 2426 |
| Rituximab Maintenance | 3717 | 2184 |
Proportion of patients who maintain remission at 24 and 48 months (NCT01697267)
Timeframe: 24 and 48 months
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Month 24 | Month 48 | |
| Azathioprine Maintenance | 70 | 44 |
| Rituximab Maintenance | 73 | 54 |
The primary efficacy outcome measure of the trial is relapse-free survival, where a relapse is either major or minor. The primary analysis will be a Cox regression model adjusted for the stratification factors (ANCA type, relapse severity and prednisone induction regimen) for the difference in the distribution of relapse-free survival between the rituximab arm and the azathioprine (control) arm (two-sided at α-level of 5%). (NCT01697267)
Timeframe: Any patients who have not relapsed at up to a maximum of 4 years will be censored.
| Intervention | participants (Number) | ||
|---|---|---|---|
| Total number of patients with a relapse | Total number of patients with a relapse during treatment | Total number of patients with a relapse post treatment | |
| Azathioprine Maintenance | 60 | 32 | 28 |
| Rituximab Maintenance | 38 | 13 | 25 |
Number of disease relapse added with the number of SAE in each group (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | Number of events (Number) |
|---|---|
| B Cell Reconstitution | 27 |
| Serologic ANCA Flare | 36 |
The rituximab utilization was measured in how many times a subject received Rituximab throughout the study which was then averaged for all subjects in each treatment arm, including those who did not receive any infusion. (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | Infusions per subject (Mean) |
|---|---|
| B Cell Reconstitution | 3.6 |
| Serologic ANCA Flare | 0.5 |
The Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG ) is a form with 34 predefined items grouped into 9 organ systems. The items are clinical features observed in patients with active ANCA vasculitis. Each item has a specified weight of either 3 or 1, depending on whether it reflects major or minor disease activity. The total BVAS/WG score is the weighted sum of individual manifestations that are present and believed to be due to active ANCA vasculitis. Higher scores reflect more active disease. BVAS/WG scores range from 0 to 64. (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | number of events (Number) |
|---|---|
| B Cell Reconstitution | 4 |
| Serologic ANCA Flare | 7 |
Number of patients with serious adverse events (SAEs), including all episodes of late onset neutropenia (LON). SAE are defined in the Serious adverse event section. Serious adverse events were reported over the entire study period (5.5 years) (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | Participants (Count of Participants) |
|---|---|
| B Cell Reconstitution | 15 |
| Serologic ANCA Flare | 14 |
Hypogammaglobulinemia defined as an IgG < 250mg/dL (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | Participants (Count of Participants) |
|---|---|
| B Cell Reconstitution | 1 |
| Serologic ANCA Flare | 0 |
number of deaths throughout the study. (NCT02749292)
Timeframe: 5.5 years
| Intervention | number of deaths (Number) |
|---|---|
| B Cell Reconstitution | 2 |
| Serologic ANCA Flare | 0 |
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status and is commonly used in health economics as a variable in the quality-adjusted life year calculation to determine the cost-effectiveness of a health treatment. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. (NCT02749292)
Timeframe: Assessed throughout the study period, every 6 months unless such time point was not reached or was missed by the patient. Median follow-up period is of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | score on a scale (Mean) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Physical functioning at 6 months | Role functioning/physical at 6 months | Role functioning/emotional at 6 months | Energy/fatigue at 6 months | Emotional well-being at 6 months | Social functioning at 6 months | Pain at 6 months | General health at 6 months | Physical functioning at 36 months | Role functioning/physical at 36 months | Role functioning/emotional at 36 months | Energy/fatigue at 36 months | Emotional well-being at 36 months | Social functioning at 36 months | Pain at 36 months | General health at 36 months | Physical functioning at 12 months | Role functioning/physical at 12 months | Role functioning/emotional at 12 months | Energy/ fatigue at 12 months | Emotional well-being at 12 months | Social functioning at 12 months | Pain at 12 months | General health at 12 months | Physical functioning at 18 months | Role functioning/physical at 18 months | Role functioning/emotional at 18 months | Energy/fatigue at 18 months | Emotional well-being at 18 months | Social functioning at 18 months | Pain at 18 months | General health at 18 months | Physical functioning at 24 months | Role functioning/physical at 24 months | Role functioning/emotional at 24 months | Energy/fatigue at 24 months | Emotional well-being at 24 months | Social functioning at 24 months | Pain at 24 months | General health at 24 months | Physical functioning at 30 months | Role functioning/physical at 30 months | Role functioning/emotional at 30 months | Energy/fatigue at 30 months | Emotional well-being at 30 months | Social functioning at 30 months | Pain at 30 months | General health at 30 months | Physical functioning at 42 months | Role functioning/physical at 42 months | Role functioning/emotional at 42 months | Energy/fatigue at 42 months | Emotional well-being at 42 months | Social functioning at 42 months | Pain at 42 months | General health at 42 months | Physical functioning at 48 months | Role functioning/physical at 48 months | Role functioning/emotional at 48 months | Energy/fatigue at 48 months | Emotional well-being at 48 months | Social functioning at 48 months | Pain at 48 months | General health at 48 months | Physical functioning at 60 months | Role functioning/physical at 60 months | Role functioning/emotional at 60 months | Energy/fatigue at 60 months | Emotional well-being at 60 months | Social functioning at 60 months | Pain at 60 months | General health at 60 months | |
| Serologic ANCA Flare | 82 | 65 | 75 | 67 | 81 | 88 | 82 | 63 | 88 | 79 | 82 | 73 | 84 | 95 | 87 | 70 | 82 | 63 | 68 | 65 | 81 | 86 | 80 | 63 | 82 | 62 | 74 | 68 | 81 | 92 | 82 | 67 | 88 | 71 | 80 | 76 | 85 | 94 | 82 | 70 | 88 | 72 | 80 | 72 | 84 | 94 | 83 | 70 | 82 | 60 | 76 | 70 | 85 | 87 | 82 | 63 | 95 | 100 | 100 | 75 | 85 | 100 | 80 | 75 | 92 | 100 | 89 | 71 | 83 | 92 | 83 | 70 |
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status and is commonly used in health economics as a variable in the quality-adjusted life year calculation to determine the cost-effectiveness of a health treatment. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. (NCT02749292)
Timeframe: Assessed throughout the study period, every 6 months unless such time point was not reached or was missed by the patient. Median follow-up period is of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | score on a scale (Mean) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Physical functioning at 6 months | Role functioning/physical at 6 months | Role functioning/emotional at 6 months | Energy/fatigue at 6 months | Emotional well-being at 6 months | Social functioning at 6 months | Pain at 6 months | General health at 6 months | Physical functioning at 36 months | Role functioning/physical at 36 months | Role functioning/emotional at 36 months | Energy/fatigue at 36 months | Emotional well-being at 36 months | Social functioning at 36 months | Pain at 36 months | General health at 36 months | Physical functioning at 12 months | Role functioning/physical at 12 months | Role functioning/emotional at 12 months | Energy/ fatigue at 12 months | Emotional well-being at 12 months | Social functioning at 12 months | Pain at 12 months | General health at 12 months | Physical functioning at 18 months | Role functioning/physical at 18 months | Role functioning/emotional at 18 months | Energy/fatigue at 18 months | Emotional well-being at 18 months | Social functioning at 18 months | Pain at 18 months | General health at 18 months | Physical functioning at 24 months | Role functioning/physical at 24 months | Role functioning/emotional at 24 months | Energy/fatigue at 24 months | Emotional well-being at 24 months | Social functioning at 24 months | Pain at 24 months | General health at 24 months | Physical functioning at 30 months | Role functioning/physical at 30 months | Role functioning/emotional at 30 months | Energy/fatigue at 30 months | Emotional well-being at 30 months | Social functioning at 30 months | Pain at 30 months | General health at 30 months | Physical functioning at 42 months | Role functioning/physical at 42 months | Role functioning/emotional at 42 months | Energy/fatigue at 42 months | Emotional well-being at 42 months | Social functioning at 42 months | Pain at 42 months | General health at 42 months | Physical functioning at 48 months | Role functioning/physical at 48 months | Role functioning/emotional at 48 months | Energy/fatigue at 48 months | Emotional well-being at 48 months | Social functioning at 48 months | Pain at 48 months | General health at 48 months | Physical functioning at 54 months | Role functioning/physical at 54 months | Role functioning/emotional at 54 months | Energy/fatigue at 54 months | Emotional well-being at 54 months | Social functioning at 54 months | Pain at 54 months | General health at 54 months | Physical functioning at 60 months | Role functioning/physical at 60 months | Role functioning/emotional at 60 months | Energy/fatigue at 60 months | Emotional well-being at 60 months | Social functioning at 60 months | Pain at 60 months | General health at 60 months | |
| B Cell Reconstitution | 84 | 66 | 79 | 65 | 83 | 89 | 79 | 66 | 74 | 50 | 65 | 58 | 76 | 83 | 69 | 60 | 79 | 61 | 82 | 65 | 86 | 92 | 81 | 66 | 83 | 70 | 88 | 69 | 85 | 96 | 84 | 68 | 83 | 71 | 84 | 68 | 82 | 91 | 81 | 69 | 85 | 74 | 87 | 64 | 81 | 90 | 86 | 60 | 76 | 58 | 67 | 60 | 77 | 85 | 83 | 59 | 65 | 67 | 67 | 52 | 73 | 65 | 70 | 61 | 88 | 50 | 67 | 67 | 84 | 84 | 81 | 59 | 72 | 33 | 100 | 48 | 82 | 63 | 53 | 58 |
Number of infections mild and severe, whether they were treated or not with antibiotics (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | number of events (Number) | |
|---|---|---|
| Serious Adverse Events- Infections | Adverse Events- Infections | |
| B Cell Reconstitution | 12 | 72 |
| Serologic ANCA Flare | 6 | 59 |
Relapses recording period was from 6/1/2016 to 12/31/2021. The outcome was reported as the number of participants with disease relapse who had either positive ANCA titers specific for myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA). The Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG ) is a form with 34 predefined items grouped into 9 organ systems. The items are clinical features observed in patients with active ANCA vasculitis. Each item has a specified weight of either 3 or 1, depending on whether it reflects major or minor disease activity. The total BVAS/WG score is the weighted sum of individual manifestations that are present and believed to be due to active ANCA vasculitis. Higher scores reflect more active disease. BVAS/WG scores range from 0 to 64. (NCT02749292)
Timeframe: Median follow-up period of 4.1 years (IQR, 2.5 - 5.0)
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| PR3 | MPO | |
| B Cell Reconstitution | 1 | 4 |
| Serologic ANCA Flare | 7 | 7 |
The Vasculitis Damage Index (VDI) is a validated formal assessment tool in ANCA-associated vasculitis clinical trials. The VDI distinguishes vasculitis-induced chronic damage from active inflammation or persistent disease. Each item represents a disease manifestation and is given a score (of 1) if present for at least 3 months. Neither the cause of damage (vasculitis vs treatment) nor an ongoing activity are taken into consideration. The VDI includes 64 items categorized into 11 groups (by organ system) and the scored items are summed to give a total score ranging from 0 to 64. A higher score means more accrued damage. (NCT02749292)
Timeframe: 3 years starting at inclusion
| Intervention | score on a scale (Mean) | |
|---|---|---|
| VDI at inclusion | VDI at 3 years | |
| B Cell Reconstitution | 1.27 | 1.42 |
| Serologic ANCA Flare | 1.07 | 1.08 |
34 reviews available for prednisolone and Angiitis
| Article | Year |
|---|---|
Hard bilateral syphilitic testes with vasculitis: a case report and literature review.
Topics: Adrenal Insufficiency; Ampicillin; Angiography; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dia | 2021 |
[Multiple mononeuropathy associated with systemic sclerosis with vasculitis confirmed by nerve biopsy: a case report].
Topics: Aged; Biopsy; Female; Glucocorticoids; Humans; Mononeuropathies; Neural Conduction; Prednisolone; Sc | 2019 |
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant | 2020 |
Superior Mesenteric Artery Vasculitis in Behçet's Disease: A Case Report and Literature Review.
Topics: Abdominal Pain; Anti-Inflammatory Agents; Behcet Syndrome; Glucocorticoids; Humans; Male; Mesenteric | 2019 |
[A case of Churg-Strauss syndrome with short duration from the onset of asthma to diagnosis of vasculitis].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Asthma; Churg-Strauss Syndrome; Female; Humans; Peroxi | 2013 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
[Vasculitic neuropathy: novel classification, diagnosis and treatment].
Topics: Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Humans; Immun | 2014 |
Renal & ocular targets for therapy in Wegener's granulomatosis.
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2009 |
Adverse effects of therapy for ANCA-associated vasculitis.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therap | 2009 |
[Ocular involvement in connective tissue diseases and vasculitides].
Topics: Adrenal Cortex Hormones; Biological Products; Blindness; Connective Tissue Diseases; Diagnosis, Diff | 2010 |
Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease.
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Female; Graves | 2002 |
[Malignant rheumatoid arthritis in the young with polyneuritis as an initial symptom].
Topics: Adolescent; Arthritis, Juvenile; Drug Therapy, Combination; Erythema; Female; Humans; Methotrexate; | 2004 |
[Nephropathies in patients with collagen diseases].
Topics: Combined Modality Therapy; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythema | 2004 |
[Manifestations mimicking relapsing polychondritis in a patient with microscopic polyangiitis].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Drug Thera | 2005 |
[Allergic granulomatosis angiitis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Asthma; Biomarkers; Churg-Strauss Syndrome; | 2005 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Et | 2005 |
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Contrai | 2007 |
[Diagnosis and therapy for vasculitis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Antigen-Antibody Complex; Autoantibodies; Drug Therapy, Comb | 2007 |
Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Male; Middle Aged; Neoplasms; Par | 2008 |
Primary angiitis of the central nervous system: report of two cases and review of the literature.
Topics: Adult; Biopsy; Cerebral Angiography; Cerebral Arteries; Cerebrovascular Disorders; Cyclophosphamide; | 1995 |
[Case of hypertrophic meningitis with vasculitis syndrome].
Topics: Azathioprine; Female; Humans; Hypertrophy; Meningitis; Middle Aged; Prednisolone; Vasculitis | 1994 |
[Corticosteroid therapy in collagen disease].
Topics: Collagen Diseases; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Prednisolone; Vasculit | 1994 |
[Multiple mononeuritis and cerebral meningo-arteritis. Wegener disease or Lyme disease?].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Cerebral Angiography; Cyclophosphamide | 1993 |
ANCA-associated vasculitis: diagnosis and treatment in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoantibodies; Cyclophosphamide; Female; Humans; | 1996 |
[Hepatitis C-associated vasculitic mononeuritis multiplex].
Topics: Chronic Disease; Cryoglobulinemia; Diagnosis, Differential; Female; Foot; Foot Diseases; Glucocortic | 1997 |
Idiopathic eosinophilic myositis associated with vasculitis and symmetrical polyneuropathy.
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Eosinophilia; Female; Humans; Muscle, Skele | 1997 |
Vasculitis--diagnosis and treatment.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Female; Giant Cell A | 1999 |
[Polyangiitis overlap syndrome].
Topics: Cyclophosphamide; Diagnosis, Differential; Humans; Mononeuropathies; Prednisolone; Prognosis; Syndro | 2000 |
[Microscopic polyangiitis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Diagnosis, Differential; Humans; Prednisolone; Prognosis; Va | 2000 |
[Cogan's syndrome].
Topics: Autoimmunity; Diagnosis, Differential; Humans; Immunosuppressive Agents; Keratitis; Meniere Disease; | 2000 |
Combination therapy in autoimmune disease: vasculitis.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Cyclophosphamide; Drug Therapy, Combination; Humans; | 2001 |
Primary systemic vasculitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Churg-Strauss | 2001 |
Renal disease and vasculitis.
Topics: Antineoplastic Agents; Child; Humans; Kidney; Kidney Diseases; Plasma Exchange; Prednisolone; Progno | 1988 |
[Steroid hormone and non-steroid anti-inflammatory agent therapy of vasculitis].
Topics: Anti-Inflammatory Agents; Betamethasone; Humans; Hydrocortisone; Prednisolone; Thrombosis; Vasculiti | 1985 |
7 trials available for prednisolone and Angiitis
| Article | Year |
|---|---|
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Topics: Biopsy; Denmark; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms; Osteo | 2017 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, C | 2003 |
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, C | 2003 |
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, C | 2003 |
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, C | 2003 |
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclo | 2004 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Dos | 2005 |
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Contrai | 2007 |
Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclophosphamide; Dr | 1997 |
216 other studies available for prednisolone and Angiitis
| Article | Year |
|---|---|
IgA vasculitis mimicking drug-induced skin reaction and infectious colitis in an elderly patient: A case report.
Topics: Abdominal Pain; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Diarr | 2021 |
IgA vasculitis with transient glomerular hematuria, diarrhea, and pericarditis following COVID-19 mRNA vaccination in a young patient with possible pre-existing ulcerative colitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Colitis, Ulcerative; COVID-19; COVID-19 Vaccines; Diarrhea; | 2023 |
Topics: Humans; Pain; Peripheral Nervous System Diseases; Prednisolone; Time-to-Treatment; Vasculitis | 2023 |
[Large-vessel vasculitis developed after use of long-acting granulocyte colony-stimulating factor in a patient with diffuse large B-cell lymphoma].
Topics: Aged; Fever; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; P | 2023 |
Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).
Topics: Adenine; Aged; Cryoglobulinemia; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; | 2019 |
[IgA vasculitis with massive hemorrhage from the jejunum after steroid administration].
Topics: Anti-Inflammatory Agents; Gastrointestinal Hemorrhage; Humans; Immunoglobulin A; Jejunum; Male; Midd | 2020 |
Extensive large vessel vasculitis presenting with pyrexia of unknown origin.
Topics: Aged; Fever; Glucocorticoids; Humans; Male; Positron Emission Tomography Computed Tomography; Predni | 2020 |
Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Female; Hereditary Complement Defic | 2020 |
Nonsystemic vasculitic neuropathy in a patient with IgG-monoclonal gammopathy of undetermined significance: A case report.
Topics: Aged; Biopsy; Female; Glucocorticoids; Humans; Immunoglobulin G; Monoclonal Gammopathy of Undetermin | 2020 |
Cutaneous arteriolitis: A novel cutaneous small vessel vasculitis disorder clinicopathologically different from cutaneous polyarteritis nodosa and cutaneous venulitis.
Topics: Adult; Arterioles; Arteritis; Arthralgia; Diagnosis, Differential; Fever; Glucocorticoids; Humans; M | 2020 |
Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Complement System Proteins; Female; Glome | 2020 |
Recurrent cutaneous necrotising eosinophilic vasculitis.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Dexamethasone; Eosinophilia; Glucocorticoids; Humans | 2021 |
Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma.
Topics: Female; Glucocorticoids; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphot | 2020 |
Acne fulminans concomitant with vasculitis-like symptoms mimicking Henoch-Schoenlein purpura.
Topics: Acne Vulgaris; Adolescent; Arthralgia; Fever; Humans; IgA Vasculitis; Isotretinoin; Male; Prednisolo | 2020 |
Rapid response to combination of hydroxychloroquine and prednisolone in a patient with refractory hypocomplementemic urticarial vasculitis.
Topics: Humans; Hydroxychloroquine; Prednisolone; Urticaria; Vasculitis | 2020 |
Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection.
Topics: Aged; Antibodies, Viral; Arthritis, Reactive; C-Reactive Protein; COVID-19; COVID-19 Serological Tes | 2021 |
Durvalumab-associated vasculitis presenting as 'the blue toe syndrome'.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Blue Toe Syndrome; | 2020 |
Development of a prediction model of treatment response in patients with cutaneous arteritis: Insights from a cohort of 33 patients.
Topics: Arteritis; Humans; Male; Polyarteritis Nodosa; Prednisolone; Retrospective Studies; Skin; Vasculitis | 2021 |
Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Coronary Vessels; Endothelial Cells; HMGB1 Protein; Human | 2021 |
An Unusual Cause of Right Upper Abdominal Pain.
Topics: Abdominal Pain; Aged; Behcet Syndrome; Celiac Artery; Cyclophosphamide; Erythema Nodosum; Female; Gl | 2022 |
Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Exanthema; Fever; Glucocorticoids; Hu | 2021 |
Large vessel vasculitis in Behçet's disease.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Behcet Syndrome; Coronary Angiography; Coron | 2017 |
Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
Topics: Adaptor Proteins, Signal Transducing; Adult; Autoimmune Diseases; Biomarkers; Bone Density; Bone Den | 2018 |
Fatal colitis associated with active systemic lupus erythematosus complicated by cytomegalovirus superinfection.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fatal Outcome; Female; Ganciclovir; H | 2017 |
IgA Vasculitis with Simultaneous Cardiopulmonary Involvement.
Topics: Anti-Inflammatory Agents; Humans; IgA Vasculitis; Immunoglobulin A; Male; Middle Aged; Prednisolone; | 2018 |
Prolonged Dry Cough without Pulmonary Changes on Radiological Imaging.
Topics: Adolescent; Anti-Inflammatory Agents; Aorta, Thoracic; Cough; Humans; Lung; Male; Prednisolone; Taka | 2018 |
Overlapping Syndrome of Systemic Scleroderma and Cryoglobulinemic Vasculitis.
Topics: Cryoglobulinemia; Female; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Prednisolone; Sc | 2019 |
Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis.
Topics: Acute Disease; Antibodies, Antineutrophil Cytoplasmic; Capillaries; Chest Pain; Child; Female; Hemor | 2019 |
[Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)--a report of three cases].
Topics: Adolescent; Choroid; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Huma | 2012 |
[Long-term data from the CYCLOPS study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2013 |
A case of hypocomplementaemic urticarial vasculitis with a high serum level of rheumatoid factor.
Topics: Aged; Anti-Inflammatory Agents; Colchicine; Complement System Proteins; Female; Gout Suppressants; H | 2013 |
ANCA-negative Wegener's granulomatosis with multiple lower cranial nerve palsies.
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Agents, Alkylating; | 2013 |
Florid urticarial vasculitis heralding a flare up of ulcerative colitis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Colitis, Ulcerative; Humans; | 2014 |
Testicular lymphocytic vasculitis treated with prednisolone and azathioprine.
Topics: Aged; Azathioprine; Drug Therapy, Combination; Humans; Male; Prednisolone; Testicular Diseases; Test | 2017 |
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Topics: Aged; Fascia; Humans; Magnetic Resonance Imaging; Male; Microscopic Polyangiitis; Muscle Fibers, Ske | 2015 |
Behçet's syndrome with gangrenous bilateral lower limbs.
Topics: Adult; Amputation, Surgical; Anti-Inflammatory Agents; Azathioprine; Behcet Syndrome; Female; Gangre | 2016 |
Epididymitis with Epididymal Cyst Indicating Immunoglobulin A Vasculitis in an AdultAi Nanbu, Kazumitsu Sugiura, Naoto Sassa, Masashi Akiyama.
Topics: Adult; Biopsy; C-Reactive Protein; Cysts; Diagnosis, Differential; Epididymitis; Glucocorticoids; Hu | 2016 |
IgG4-Related Sialoadenitis with a Skin Lesion and Multiple Mononeuropathies Suggesting Coexistent Cryoglobulinemic Vasculitis.
Topics: Aged; Cryoglobulinemia; Humans; Immunoglobulin G; Male; Mononeuropathies; Plasma Cells; Prednisolone | 2016 |
Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Brain; Central Nervous System; Epstein-Barr V | 2017 |
A novel case of renal pathergy reaction in a Behçet's disease patient complicated by IgA vasculitis.
Topics: Behcet Syndrome; Colchicine; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Kid | 2017 |
[ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; H | 2008 |
A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection.
Topics: Adolescent; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Catastrophic Illness; Diagnostic Er | 2008 |
Cryoglobulinemic vasculitis in pregnancy.
Topics: Adult; Complement C4; Cryoglobulinemia; Exanthema; Female; Glucocorticoids; Humans; Immunoglobulin G | 2008 |
[Case of pulmonary nocardia infection complicated with microscopic polyangiitis during its course].
Topics: Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Humans; Immunocompromised Hos | 2008 |
Frosted branch angiitis associated with streptococcal infection: optical coherence tomography as a follow-up tool.
Topics: Administration, Oral; Administration, Topical; Angiography; Anti-Inflammatory Agents; Atropine; Beta | 2009 |
Cryoglobulinemia presenting as acute polyneuropathy.
Topics: Acute Disease; Cryoglobulinemia; Cryoglobulins; Diagnosis, Differential; Enzyme-Linked Immunosorbent | 2008 |
A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Glucocorticoids; Humans; Immunosuppressive Agents; Lu | 2009 |
Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience.
Topics: Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Female; Humans; Japan; Kidney Failu | 2009 |
[Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytopla | 2009 |
Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.
Topics: Administration, Oral; Aged; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Drug Therapy, | 2010 |
[Case of microscopic polyangiitis presenting initially as prostatic vasculitis].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Biopsy; Diagnosis, Differential; Early Dia | 2009 |
Cutaneous Mycobacterium intracellulare infection in a bone marrow transplantation recipient.
Topics: Bone Marrow Transplantation; Clarithromycin; Graft vs Host Disease; Humans; Immunocompromised Host; | 2010 |
Complete remission of coronary vasculitis in Churg-Strauss Syndrome by prednisone and cyclophosphamide.
Topics: Adolescent; Churg-Strauss Syndrome; Coronary Disease; Coronary Vessels; Cyclophosphamide; Drug Thera | 2013 |
A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Fe | 2009 |
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy.
Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridam | 2013 |
Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α.
Topics: Administration, Oral; Adult; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antirhe | 2010 |
Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; | 2011 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; | 2011 |
Colitis associated with active systemic lupus erythematosus successfully treated with rituximab.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Colitis; Colo | 2011 |
A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement.
Topics: Adult; Angiography, Digital Subtraction; Azathioprine; Brain; Central Nervous System Diseases; Diagn | 2012 |
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Int | 2011 |
Frosted branch angiitis, presumably related to dermatomyositis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Asian People; Dermatomyositis; Diagnosis, Dif | 2011 |
Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institut
Topics: Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antibodies, Antineutrophil Cytoplasmic; Fema | 2011 |
Mesenteric vasculitis with genitourinary tract involvement in systemic lupus erythematosus.
Topics: Cyclophosphamide; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Male Urogenital Dise | 2011 |
Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus.
Topics: Bone Marrow; Dose-Response Relationship, Drug; Female; Fever; Humans; Immunosuppressive Agents; Lupu | 2012 |
Central retinal artery occlusion and recurrent papillitis in a patient with incomplete Behçet disease.
Topics: Adult; Behcet Syndrome; Glucocorticoids; Humans; Male; Papilledema; Prednisolone; Retinal Artery Occ | 2011 |
Vasculitis of the central and peripheral nervous system mimicking brain death.
Topics: Adult; Anti-Inflammatory Agents; Blood Vessels; Brain Death; Cyclophosphamide; Electroencephalograph | 2012 |
Risk factors associated with relapse in Japanese patients with microscopic polyangiitis.
Topics: Aged; Asian People; Cyclophosphamide; Dose-Response Relationship, Drug; Erythrocyte Count; Female; H | 2012 |
Clofazimine-induced enteropathy in treatment-resistant nodular vasculitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Clofazimine; Drug Therapy, Co | 2012 |
Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome.
Topics: Adolescent; Antiphospholipid Syndrome; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydro | 2012 |
Intestinal obstruction as the initial presentation of lupus mesenteric vasculitis.
Topics: Antirheumatic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; | 2012 |
Spontaneous pneumomediastinum: a rare complication of juvenile dermatomyositis.
Topics: Child; Dermatomyositis; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstiti | 2012 |
Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Diagnostic Techniques, Ophthalmological; Drug Combin | 2001 |
Bilateral panuveitis in a child with hypohidrotic ectodermal dysplasia.
Topics: Child; Ectodermal Dysplasia; Epiretinal Membrane; Glucocorticoids; Humans; Hypohidrosis; Male; Pain; | 2002 |
Cutaneous lymphocytic vasculitis as the presenting feature of acute lymphoblastic leukemia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biopsy; Bone Marrow; Child; Humans; Precursor Cell Lym | 2002 |
[ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata].
Topics: Acne Vulgaris; Adult; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Diagnosis, Different | 2002 |
Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: report of five cases.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Autoimmune Diseases; Female; Glomerulo | 2002 |
Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade.
Topics: Aged; Antibodies, Monoclonal; Churg-Strauss Syndrome; Cyclophosphamide; Etanercept; Female; Glucocor | 2002 |
Indocyanine green angiography in a case of unilateral recurrent posterior acute multifocal placoid pigment epitheliopathy.
Topics: Acute Disease; Adult; Choroid; Coloring Agents; Fluorescein Angiography; Glucocorticoids; Humans; In | 2003 |
[Initial results of multicenter, randomized, controlled therapy studies for ANCA-associated vasculitis].
Topics: Administration, Oral; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Clinical Tri | 2003 |
[COMPLICATIONS FOLLOWING PREDNISOLONE THERAPY OF ALLERGIC PAPULO-NECROTIC VASCULITIS].
Topics: Dermatitis; Gangrene; Humans; Necrosis; Osteoporosis; Pathology; Prednisolone; Purpura; Pyoderma; St | 1964 |
[COMPLICATIONS DURING PREDNISOLONE THERAPY OF A PAPULO-NECROTIC FORM OF ALLERGIC VASCULITIS].
Topics: Drug Therapy; Necrosis; Pathology; Prednisolone; Purpura; Toxicology; Vasculitis | 1965 |
Systemic vasculitis presenting with acute gastrointestinal hemorrhage: case report and review of the literature.
Topics: Acute Disease; Adult; Female; Gastrointestinal Hemorrhage; Glucocorticoids; Humans; Prednisolone; Va | 2003 |
[Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; G | 2003 |
Atypical Cogan's syndrome presenting with bilateral acute glaucoma.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Female; Glaucoma; Hearing Loss, Sensorineural; Human | 2004 |
Cyanotic change of colon mucosa in a patient with Raynaud's phenomenon.
Topics: Aged; Colon; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Prednisolone; Radiograp | 2004 |
Orbital vasculitis following varicella. A case report.
Topics: Adult; Anti-Inflammatory Agents; Chickenpox; Female; Humans; Orbit; Prednisolone; Tomography, X-Ray | 2004 |
Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child.
Topics: Anti-Inflammatory Agents; Child; Chronic Disease; Diagnosis, Differential; Humans; Male; Parvovirida | 2005 |
Gallbladder vasculitis associated with cutaneous leucocytoclastic vasculitis.
Topics: Aged; Cholelithiasis; Diagnosis, Differential; Female; Gallbladder Diseases; Humans; Prednisolone; S | 2004 |
Testicular involvement in rheumatoid vasculitis.
Topics: Administration, Oral; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Glucocorti | 2004 |
Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis.
Topics: Antibodies, Anticardiolipin; Antibodies, Antineutrophil Cytoplasmic; Colitis, Ulcerative; Humans; Ma | 2006 |
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2005 |
[Nonsystemic vasculitic neuropathy treated with steroid and azathioprine].
Topics: Aged; Azathioprine; Fever of Unknown Origin; Humans; Immunosuppressive Agents; Male; Peripheral Nerv | 2005 |
[Serum amyloid protein A was a useful marker for steroid tapering in a case of MPO-ANCA-associated vasculitis].
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Humans; Male; Middle A | 2005 |
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with di
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; B-Cell Activatin | 2006 |
Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers.
Topics: Aged; Cryoglobulinemia; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressiv | 2007 |
Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephro
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Bacterial Toxins; Calcineuri | 2006 |
Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement.
Topics: Adolescent; Child; Dermatomyositis; Hepatitis, Chronic; Humans; Lung; Lung Diseases, Interstitial; M | 2006 |
[Pathological changes of the blood vessels in rabbit femoral head with glucocorticoid-induced necrosis].
Topics: Animals; Blood Vessels; Female; Femur Head; Femur Head Necrosis; Male; Prednisolone; Rabbits; Random | 2006 |
Juvenile idiopathic arthritis with peripheral gangrene.
Topics: Amputation, Surgical; Antirheumatic Agents; Arthritis, Juvenile; Child, Preschool; Foot; Gangrene; H | 2006 |
The occurrence of sensorineural hearing loss in a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-related microscopic polyangiitis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Female; Hearing Loss, Sensor | 2007 |
A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma.
Topics: Aged; Alendronate; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Combined Chemotherapy Prot | 2006 |
[Churg-Strauss syndrome. Main symptoms: asthma, eosinophilia, vasculitis symptoms (especially mononeuritis multiplex)].
Topics: Antibodies, Antineutrophil Cytoplasmic; Asthma; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis, | 2006 |
Urticarial vasculitis and Castleman's disease.
Topics: Adult; Anti-Inflammatory Agents; Castleman Disease; Glucocorticoids; Humans; Male; Prednisolone; Rec | 2007 |
[An autopsy case of microscopic polyangiitis complicated with pulmonary aspergilloma and cytomegalovirus pneumonia].
Topics: Aged; Alzheimer Disease; Antibodies, Antineutrophil Cytoplasmic; Aspergillosis; Cytomegalovirus Infe | 2007 |
Vasculitic neuropathy in a patient with hereditary C1 inhibitor deficiency.
Topics: Adult; Anti-Inflammatory Agents; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein | 2007 |
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Blood Vessels; Colchicine; Daps | 2007 |
Thrombotic microangiopathy due to malignant hypertension following corticosteroid therapy for microscopic polyangitis.
Topics: Adrenal Cortex Hormones; Aged; Endothelium, Vascular; Female; Humans; Hypertension, Malignant; Predn | 2007 |
Extensive medium-vessel vasculitis with SLE: an unusual association.
Topics: Adolescent; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Eryth | 2007 |
[Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Female; G | 2007 |
Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease.
Topics: Anemia, Hemolytic; Antirheumatic Agents; Cyclosporine; Dermatomyositis; Female; Humans; Lung Disease | 2007 |
[Severe chronic headache with depression induced by pachymeningitis in Wegener's granulomatosis].
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antidepressive | 2008 |
Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antineutrophil | 2008 |
[Administration of prostaglandins Ei and immunotherapy in management of various-genesis trophic ulcers].
Topics: Administration, Oral; Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Chronic Dis | 2007 |
Autoerythrocyte sensitization syndrome (Gardner-Diamond syndrome) associated with cutaneous vasculitis.
Topics: Antipsychotic Agents; Autoantibodies; Autoimmune Diseases; Colchicine; Drug Therapy, Combination; Ec | 2008 |
Systemic sclerosis associated with generalized vasculitis and hypopituitarism.
Topics: Anti-Inflammatory Agents; Female; Humans; Hypopituitarism; Hypothyroidism; Middle Aged; Prednisolone | 2008 |
Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange.
Topics: Azathioprine; Biopsy; Diagnosis, Differential; Extremities; Female; Humans; Lupus Erythematosus, Sys | 1982 |
Steroids in renal disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Glomerulonephritis; Glomerulosclerosis, Focal | 1982 |
Cerebral angiitis and intracerebral hemorrhage associated with methamphetamine abuse. Case report.
Topics: Adolescent; Cerebral Hemorrhage; Cerebrovascular Disorders; Epilepsy, Tonic-Clonic; Humans; Male; Me | 1983 |
Digital vasculitis in patients with cryptogenic fibrosing alveolitis.
Topics: Adult; Aged; Female; Fingers; Humans; Immunosuppressive Agents; Male; Middle Aged; Penicillamine; Pr | 1984 |
[Cutaneous coumarin necrosis of the breast].
Topics: 4-Hydroxycoumarins; Breast Diseases; Bromhexine; Cimetidine; Female; Furosemide; Humans; Middle Aged | 1983 |
A case of chronic gastrointestinal blood loss in cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cystic Fibrosis; Gastrointestinal Hemorrhage; Huma | 1995 |
[Multiple colonic ulcers in a patient with Sjögren's syndrome].
Topics: Adult; Anti-Inflammatory Agents; Colonic Diseases; Female; Humans; Prednisolone; Sjogren's Syndrome; | 1995 |
Churg-Strauss syndrome associated with third nerve palsy and mononeuritis multiplex of the legs.
Topics: Abducens Nerve; Cerebral Palsy; Churg-Strauss Syndrome; Female; Humans; Middle Aged; Nerve Degenerat | 1995 |
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis.
Topics: Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Pre | 1994 |
Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Biomarkers; Cyclophosphamide; Enzyme-Linked | 1995 |
Relapses in patients with a systemic vasculitis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Azathioprine | 1993 |
[Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].
Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Prednisolone; Vasculitis | 1994 |
Atypical peritracheobronchial vasculitis and an effective treatment.
Topics: Autoantibodies; Diagnosis, Differential; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged | 1994 |
Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis.
Topics: Adenocarcinoma; Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Biomarkers; Cyclophosp | 1994 |
A case of chronic meningococcal meningitis.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Drainage; Humans; Male; Meningitis, Meningococcal; Ne | 1994 |
The diagnosis and management of arteritis.
Topics: Arteritis; Giant Cell Arteritis; Humans; Polyarteritis Nodosa; Prednisolone; Tomography, X-Ray Compu | 1993 |
Isolated angiitis of the central nervous system first presenting as intracranial hemorrhage during cesarean section.
Topics: Adult; Central Nervous System Diseases; Cerebral Hemorrhage; Cesarean Section; Cyclophosphamide; Dia | 1993 |
Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases.
Topics: Adolescent; Adult; Aneurysm; Behcet Syndrome; Cyclophosphamide; Drug Therapy, Combination; Humans; M | 1994 |
Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy.
Topics: Adolescent; Brain; Cyclophosphamide; Female; Humans; Meningoencephalitis; Plasmapheresis; Prednisolo | 1993 |
Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antiphospholipid; Biopsy; Female; Humans; Lupus Erythematosus, Systemic; Placenta | 1993 |
Relationship between disease activity and ANCA level by ELISA in the long-term management of vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Cyclophosphamide; Humans; Immunoglobulin G; | 1993 |
Problems of classification in necrotizing vasculitis.
Topics: Adolescent; Adult; Aged; Churg-Strauss Syndrome; Cyclophosphamide; Female; Granulomatosis with Polya | 1993 |
Rhabdomyolysis in vasculitis.
Topics: Adult; Chloroquine; Connective Tissue Diseases; Fatal Outcome; Female; Humans; Prednisolone; Rhabdom | 1993 |
Pooled intravenous immunoglobulin in the management of systemic vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Blood Sedimentation; C-Reactive Protein; Cyc | 1993 |
Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement.
Topics: Adult; Aged; Albumins; Brain Diseases; Central Nervous System Diseases; Female; Humans; Interleukin- | 1993 |
Unusual neuroradiological findings in systemic lupus erythematosus.
Topics: Activities of Daily Living; Cerebral Arterial Diseases; Drug Administration Schedule; Female; Humans | 1993 |
Late onset systemic lupus erythematosus diagnosed in an elderly man with unusual skin eruptions and sudden death.
Topics: Age of Onset; Anti-Inflammatory Agents; Death, Sudden; Diagnosis, Differential; Fluorescent Antibody | 1995 |
[Isolated angiitis of the central nervous system presenting as subcortical hemorrhage--a case report of benign type].
Topics: Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Hemorrhage; Female; Glucocorticoids; Hematoma; | 1996 |
Three HLA-A29 positive patients with uveitis.
Topics: Anti-Inflammatory Agents; Chorioretinitis; Female; Fluorescein Angiography; Follow-Up Studies; Fundu | 1996 |
Large vessel vasculitis without temporal artery involvement: isolated form of giant cell arteritis?
Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Arterial Occlusive Dise | 1996 |
Sarcoidosis and primary systemic vasculitis.
Topics: Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Fluid Therapy; Humans; Male; Methylpredn | 1996 |
Longitudinal analysis of soluble intercellular adhesion molecule 1 in retinal vasculitis patients.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Female; Humans; Intercellular Adhesion Molecule-1; Long | 1996 |
Recurrence of ANCA-associated microscopic polyangiitis after cadaveric renal transplant.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Cadaver; Female; Glomerulonephritis; Hematuria; Hemopt | 1996 |
Bilateral frosted branch angitis in an 8-year-old Indian girl.
Topics: Anti-Inflammatory Agents; Child; Exudates and Transudates; Female; Fluorescein Angiography; Fundus O | 1996 |
Cutaneous panniculitis and relapsing polychondritis: two cases.
Topics: Adult; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Middle Aged; Panniculitis; Polycho | 1996 |
Rheumatic manifestations of the myelodysplastic syndromes: a comparative study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Male; My | 1996 |
Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms.
Topics: Cryoglobulinemia; Dyspnea; Glucocorticoids; Humans; Hypoxia; Male; Middle Aged; Prednisolone; Pulmon | 1997 |
[Diffuse plane xanthoma and benign paraproteinemia].
Topics: Anti-Inflammatory Agents; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Paraproteinemias | 1995 |
Psoriatic arthritis or overlap syndrome.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Fema | 1997 |
Multiorgan sarcoidosis presenting with symmetric polyarthralgia, cutaneous vasculitis, and sicca symptoms.
Topics: Anti-Inflammatory Agents; Arthralgia; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Prednis | 1997 |
Polyangiitis overlap syndrome.
Topics: Adult; Angiography; Arterial Occlusive Diseases; Gastrointestinal Hemorrhage; Humans; Immunosuppress | 1997 |
Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Antibodies, Antineutrophil Cytoplas | 1997 |
[A case of systemic lupus erythematodes with hemosputum and pneumothorax probably resulting from pulmonary infarction and pulmonary angitis].
Topics: Adult; Anti-Inflammatory Agents; Hemoptysis; Humans; Lupus Erythematosus, Systemic; Male; Methylpred | 1998 |
[Diffuse panbronchiolitis with myeloperoxidase-specific antineutrophil cytoplasmic antibody-related vasculitis].
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Bronchiolitis; Cyclophosphamide; F | 1998 |
Unusual presentation of cutaneous vasculitis.
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Bacterial Infections; Child; Humans; Male; | 1998 |
Sarcoidosis with palpable nodular myositis, periostitis and large-vessel vasculitis stimulating Takayasu's arteritis.
Topics: Adult; Female; Humans; Muscular Diseases; Myositis; Periostitis; Prednisolone; Sarcoidosis; Takayasu | 1999 |
Diaphragmatic paresis as a manifestation of large artery vasculitis.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Axillary Artery; Diaphragm; Female; Humans; Methotre | 1999 |
Erythema elevatum diutinum complicated by rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; E | 1999 |
Frosted branch angiitis with ocular toxoplasmosis.
Topics: Adolescent; Animals; Antibodies, Protozoan; Chorioretinitis; Drug Therapy, Combination; Enzyme-Linke | 1999 |
The pituitary-adrenal axis in idiopathic retinal vasculitis.
Topics: Adult; Anti-Inflammatory Agents; Dehydroepiandrosterone Sulfate; Drug Resistance; Female; Humans; Hy | 1999 |
[Two cases of silicosis exhibiting MPO-ANCA associated disorder].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Humans; Lung Diseases, Interstitial; Male; Meningitis; | 1999 |
Rheumatoid arthritis accompanied by colonic lesions.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Barium Sulfate; Colitis, Ulcer | 2000 |
[Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cyt | 2000 |
[Two cases of classical polyarteritis nodosa associated with a low titre of MPO-ANCA].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Betamethasone; Biomarkers; D | 2000 |
Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: successful management with oral corticosteroids.
Topics: Administration, Oral; Adolescent; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Female | 2000 |
[Microscopic polyangitis with pleuritis as the only pulmonary complication].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Female; Humans; Peroxida | 2000 |
Cryoglobulinemic vasculitis resistant to intermittent intravenous pulse cyclophosphamide therapy.
Topics: Administration, Oral; Aged; Cryoglobulinemia; Cyclophosphamide; Drug Resistance; Female; Humans; Imm | 2000 |
Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Dermatitis; Female; Humans; Methotrexate; Pre | 2000 |
Labial adenocarcinoma after treatment with cyclosporin a in a patient with panuveitis.
Topics: Adenocarcinoma; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lip Neoplasms; Panuvei | 2000 |
Neovascular glaucoma as a complication of retinal vasculitis in Crohn disease.
Topics: Administration, Topical; Anti-Inflammatory Agents; Crohn Disease; Fluorescein Angiography; Fundus Oc | 2000 |
Microscopic polyarteritis with renal and cerebral involvement.
Topics: Acute Kidney Injury; Adolescent; Antibodies, Antineutrophil Cytoplasmic; Brain; Cyclophosphamide; Fe | 2000 |
Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome.
Topics: Adult; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Iritis; Male; Prednisolone; Syndrome; V | 2001 |
PFAPA syndrome (Periodic Fever, Aphthous stomatitis, Pharyngitis, Adenitis).
Topics: Azathioprine; Child; Cimetidine; Fever; Humans; Immunosuppressive Agents; Infant; Lymphadenitis; Mal | 1999 |
Classical polyarteritis nodosa and microscopic polyangiitis--a clinicopathologic study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Ch | 2001 |
Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy.
Topics: Anti-Inflammatory Agents; Complement System Proteins; Glomerulonephritis, Membranoproliferative; Glo | 2001 |
Immunosuppressive treatment for vasculitis associated with Lyme borreliosis.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lyme Disease; Male; M | 2001 |
Subclinical vasculitis in polymyalgia rheumatica.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Magnetic Resonance Imaging; Polymyalgia Rheumatica; | 2001 |
Necrotizing vasculitis in a patient with generalized morphea.
Topics: Adolescent; Arm; Cyclophosphamide; Diagnosis, Differential; Drug Administration Schedule; Female; Hu | 2001 |
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Arthritis, Rheumatoid; Biomarkers; C-Reactive | 2002 |
Juvenile dermatomyositis complicated with vasculitis and duodenal perforation.
Topics: Abdominal Abscess; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Dermatomyositis; Duode | 2001 |
Systemic lupus erythematosus associated with massive ascites and pleural effusion in a patient who presented with disseminated intravascular coagulation.
Topics: Anorexia; Antibodies, Antinuclear; Ascites; Autoimmune Diseases; Disseminated Intravascular Coagulat | 2002 |
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis | 2002 |
Coincidence of asymptomatic avascular necrosis and fracture of the femoral neck: a rare combination of glucocorticoid induced side effects.
Topics: Azathioprine; Bone Density; Female; Femoral Neck Fractures; Femur Head Necrosis; Humans; Immunosuppr | 2002 |
'Pauci-immune' rapidly progressive glomerulonephritis associated with systemic vasculitis.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Cyclophosphamide; Drug Therapy, Combi | 1992 |
Renal disease associated with circulating antineutrophil cytoplasm activity.
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Cytoplasm; Female; Fluorescent Antibody Technique; | 1992 |
[Isolated angiitis of the central nervous system with high immune complex titer, first presenting as intracranial hemorrhage during cesarean section].
Topics: Adult; Antigen-Antibody Complex; Cerebral Arterial Diseases; Cerebral Hemorrhage; Cesarean Section; | 1992 |
[Application of adrenal cortex steroid hormone therapy and the associated problems].
Topics: Churg-Strauss Syndrome; Humans; Paraproteinemias; Peripheral Nervous System Diseases; POEMS Syndrome | 1992 |
Polyarteritis nodosa with aortic dissection: necrotizing vasculitis of the vasa vasorum.
Topics: Aortic Aneurysm, Thoracic; Aortic Dissection; Autopsy; Female; Humans; Middle Aged; Necrosis; Polyar | 1992 |
Effect of a newly synthesized leukotriene antagonist, (E)-2,2-diethyl-3'-2-2-(4-isopropyl) thiazolyl ethenyl succinanilic acid (MCI-826), on immunological liver injury and nephritis in mice.
Topics: Animals; Cyclophosphamide; Glomerulonephritis; Kidney; Leukotriene Antagonists; Liver; Male; Mice; M | 1992 |
[Hearing loss in autoimmune diseases].
Topics: Aged; Autoimmune Diseases; Female; Hearing Loss, Sensorineural; Humans; Iridocyclitis; Prednisolone; | 1992 |
A case of frosted-branch retinal angiitis in a child.
Topics: Child, Preschool; Edema; Female; Fluorescein Angiography; Fundus Oculi; Humans; Iritis; Prednisolone | 1992 |
Vasculitis in association with atherosclerosis.
Topics: Arteriosclerosis; Humans; Leg Ulcer; Male; Middle Aged; Prednisolone; Vasculitis | 1992 |
Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.
Topics: Adult; Aged; Cryoglobulinemia; Cyclophosphamide; Female; Humans; Immunoglobulin G; Immunoglobulin M; | 1992 |
[Vasculitic syndrome].
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Diagnosis, Differential; Humans; Immunosuppr | 1991 |
Inner ear deafness in Wegener's granulomatosis.
Topics: Adult; Autoimmune Diseases; Cell Movement; Cyclophosphamide; Deafness; Ear, Inner; Granulomatosis wi | 1991 |
Retinal vasculitis in a mother and her son with human T-lymphotropic virus type 1 associated myelopathy.
Topics: Adult; Female; HTLV-I Antibodies; HTLV-I Infections; Humans; Male; Middle Aged; Prednisolone; Retina | 1991 |
Chronic subcorneal pustulosis with vasculitis: a variant of generalized pustular psoriasis in black South Africans.
Topics: Adult; Black People; Child; Dapsone; Female; Humans; Middle Aged; Prednisolone; Psoriasis; Retrospec | 1991 |
Hemobilia due to vasculitis of the gall bladder in a patient with mixed connective tissue disease.
Topics: Acute Disease; Adult; Cyclophosphamide; Female; Gallbladder; Gallbladder Diseases; Hemobilia; Hemorr | 1991 |
Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus.
Topics: Adult; Brain; Cerebrovascular Disorders; Female; Humans; Lupus Erythematosus, Systemic; Necrosis; Pr | 1990 |
Vasculitis in primary biliary cirrhosis--response to prednisolone.
Topics: Aged; Blindness; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Optic Nerve; Prednisolone; V | 1990 |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.
Topics: Animals; Blood Vessels; Cyclosporins; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Graft | 1989 |
Asthma and vasculitis.
Topics: Adult; Asthma; Female; Humans; Prednisolone; Vasculitis | 1989 |
[Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 5) Periarteritis nodosa and necrotic vasculitis].
Topics: Anticoagulants; Female; Humans; Immunosuppressive Agents; Male; Plasma Exchange; Polyarteritis Nodos | 1988 |
Visual recovery in orbital vasculitis.
Topics: Blindness; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Mid | 1988 |
[A patient with recurrent polychondritis, vasculitis and local focal glomerulonephritis].
Topics: Azathioprine; Drug Therapy, Combination; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hu | 1988 |
[A case of allergic granulomatous angiitis with special reference to cardiac lesions].
Topics: Adult; Cardiomyopathies; Female; Granuloma; Humans; Prednisolone; Vasculitis | 1986 |
A case of ulcerative colitis presenting as vasculitic purpura.
Topics: Barium Sulfate; Colectomy; Colitis, Ulcerative; Diarrhea; Humans; Intestinal Mucosa; Male; Middle Ag | 1985 |
The ENT manifestations of systemic vasculitis.
Topics: Azathioprine; Deafness; Ear Diseases; Female; Humans; Male; Middle Aged; Nose Diseases; Otitis Media | 1985 |
Clinicopathological profile of vasculitides in India.
Topics: Adolescent; Adult; Cyclophosphamide; Female; Humans; India; Male; Middle Aged; Necrosis; Prednisolon | 1985 |
[Rheumatoid vasculitis and malignant rheumatoid arthritis].
Topics: Antigen-Antibody Complex; Arthritis, Rheumatoid; Humans; Immunoglobulin G; Immunosuppressive Agents; | 1985 |